mp:V3.0.0 consolidatie medicatiegegevensMGR addendum: verschil tussen versies
| Regel 54: | Regel 54: | ||
|style="background-color: white;"|MBH_300_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T - 4 maanden om 08:00 uur | |style="background-color: white;"|T - 4 maanden om 08:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 107: | Regel 107: | ||
|style="background-color: white;"|MBH_300_gestopt_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_gestopt_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T - 10 dagen om 18:00 uur | |style="background-color: white;"|T - 10 dagen om 18:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 121: | Regel 121: | ||
|style="background-color: white;"|T - 10 dagen | |style="background-color: white;"|T - 10 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|MedicatieafspraakStopType |
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 131: | Regel 131: | ||
|style="background-color: white;"|Zie [[#MARCHA_VAN_PARTNERS|Zorgverlener: MARCHA_VAN_PARTNERS]] | |style="background-color: white;"|Zie [[#MARCHA_VAN_PARTNERS|Zorgverlener: MARCHA_VAN_PARTNERS]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RedenWijzigenOfStaken |
|style="background-color: white;"|geneesmiddelinteractie (code = '79899007' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | |style="background-color: white;"|geneesmiddelinteractie (code = '79899007' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 153: | Regel 153: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 173: | Regel 173: | ||
|style="background-color: white;"|MBH_300_gestopt_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |style="background-color: white;"|MBH_300_gestopt_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T - 4 maanden om 09:00 uur | |style="background-color: white;"|T - 4 maanden om 09:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 216: | Regel 216: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 236: | Regel 236: | ||
|style="background-color: white;"|MBH_300_gestopt_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |style="background-color: white;"|MBH_300_gestopt_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T - 10 dagen om 19:00 uur | |style="background-color: white;"|T - 10 dagen om 19:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 250: | Regel 250: | ||
|style="background-color: white;"|T - 10 dagen | |style="background-color: white;"|T - 10 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToedieningsafspraakStopType |
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 282: | Regel 282: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 289: | Regel 289: | ||
|style="background-color: white;"|MBH_300_gestopt_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_gestopt_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 311: | Regel 311: | ||
|style="background-color: white;"|MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T - 21 dagen om 08:02 uur | |style="background-color: white;"|T - 21 dagen om 08:02 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 361: | Regel 361: | ||
|style="background-color: white;"|MBH_300_gewijzigd_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_gewijzigd_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T - 2 dagen om 08:02 uur | |style="background-color: white;"|T - 2 dagen om 08:02 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 379: | Regel 379: | ||
|style="background-color: white;"|Zie [[#MARCHA_VAN_PARTNERS|Zorgverlener: MARCHA_VAN_PARTNERS]] | |style="background-color: white;"|Zie [[#MARCHA_VAN_PARTNERS|Zorgverlener: MARCHA_VAN_PARTNERS]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RedenWijzigenOfStaken |
|style="background-color: white;"|gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | |style="background-color: white;"|gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 401: | Regel 401: | ||
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 421: | Regel 421: | ||
|style="background-color: white;"|MBH_300_gewijzigd_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_gewijzigd_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T - 2 dagen om 08:02 uur | |style="background-color: white;"|T - 2 dagen om 08:02 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 435: | Regel 435: | ||
|style="background-color: white;"|T - 3 dagen | |style="background-color: white;"|T - 3 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|MedicatieafspraakStopType |
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 464: | Regel 464: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 484: | Regel 484: | ||
|style="background-color: white;"|MBH_300_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |style="background-color: white;"|MBH_300_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T - 21 dagen om 09:02 uur | |style="background-color: white;"|T - 21 dagen om 09:02 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 524: | Regel 524: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 544: | Regel 544: | ||
|style="background-color: white;"|MBH_300_gewijzigd_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |style="background-color: white;"|MBH_300_gewijzigd_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T - 2 dagen om 09:02 uur | |style="background-color: white;"|T - 2 dagen om 09:02 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 584: | Regel 584: | ||
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 590: | Regel 590: | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
|style="background-color: white;"|MBH_300_gewijzigd_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_gewijzigd_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| Regel 611: | Regel 604: | ||
|style="background-color: white;"|MBH_300_gewijzigd_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |style="background-color: white;"|MBH_300_gewijzigd_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T - 2 dagen om 09:02 uur | |style="background-color: white;"|T - 2 dagen om 09:02 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 625: | Regel 618: | ||
|style="background-color: white;"|T - 3 dagen | |style="background-color: white;"|T - 3 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToedieningsafspraakStopType |
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 657: | Regel 650: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 664: | Regel 657: | ||
|style="background-color: white;"|MBH_300_gewijzigd_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |style="background-color: white;"|MBH_300_gewijzigd_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 673: | Regel 666: | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| − | |} | + | |} |
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_gewijzigd_MTD1 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 684: | Regel 675: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigd_MTD1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T - 3 dagen om 07:14:44 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToedieningsDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 3 dagen om 07:14:44 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|ToegediendeHoeveelheid |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Aantal |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Eenheid | ||
| + | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Toedieningsweg |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Toediener |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"|1 | + | |style="background-color: white;"|MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieToedieningsafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="2"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"|1 | + | |style="background-color: white;"|MBH_300_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_gewijzigd_MTD2 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 737: | Regel 737: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigd_MTD2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T - 2 dagen om 07:10:26 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToedieningsDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen om 07:10:26 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|ToegediendeHoeveelheid |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Aantal |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Eenheid | ||
| + | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Toedieningsweg |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Toediener |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Geneesmiddel - primaire code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|Geneesmiddel - | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |} | + | |}<section end=MBH_MBH_300_gewijzigd /><section begin=MBH_MBH_300_gewijzigddoorander /> |
| + | ====Medicamenteuze behandeling MBH_300_gewijzigddoorander ==== | ||
| + | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_gewijzigddoorander_MA_eigen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 800: | Regel 801: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 60 dagen om 08:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T + 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 814: | Regel 815: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 14 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| Regel 824: | Regel 822: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#MARCHA_VAN_PARTNERS|Zorgverlener: MARCHA_VAN_PARTNERS]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| Regel 840: | Regel 838: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| − | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| Regel 856: | Regel 847: | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_gewijzigddoorander_MA_wijzigingdoorander |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 863: | Regel 854: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 3 dagen om 08:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 3 dagen, tot en met T + 30 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 3 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 30 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RedenWijzigenOfStaken | ||
| + | |style="background-color: white;"|gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |||
| − | |||
| − | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 900: | Regel 891: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag 2 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 906: | Regel 897: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 919: | Regel 910: | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_gewijzigddoorander_MA_techstakendoorander |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 926: | Regel 917: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigddoorander_MA_techstakendoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - 3 dagen om | + | |style="background-color: white;"|T - 3 dagen om 08:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T - 4 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 60 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 4 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MedicatieafspraakStopType | ||
| + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |||
| − | |||
| − | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 963: | Regel 954: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| − | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="4"|MBH identificatie | |
| − | + | |style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
| − | |||
| − | |||
| − | |||
| − | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_gewijzigddoorander_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 996: | Regel 980: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigddoorander_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 60 dagen om 09:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T + 14 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 1.010: | Regel 994: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 14 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
| Regel 1.039: | Regel 1.020: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| − | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| Regel 1.062: | Regel 1.036: | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_gewijzigddoorander_TA_wijziging |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.069: | Regel 1.043: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigddoorander_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - 3 dagen om | + | |style="background-color: white;"|T - 3 dagen om 09:10 uur |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 3 dagen, tot en met T + 30 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 3 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 30 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="4"|Geneesmiddel - primaire code |
| + | |style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="4"|Geneesmiddel - generiekere code | |
| − | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |colspan="4"|Geneesmiddel - | ||
| − | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| Regel 1.123: | Regel 1.080: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag 2 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| Regel 1.142: | Regel 1.099: | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_gewijzigddoorander_TA_techstaken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.149: | Regel 1.106: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigddoorander_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 3 dagen om 09:10 uur |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T - 4 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 60 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 4 dagen |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="4"|ToedieningsafspraakStopType |
| − | | | + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') |
| − | | | ||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.196: | Regel 1.146: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigddoorander_MA_techstakendoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieToedieningsafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_gewijzigddoorander_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| − | |} | + | |} |
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_gewijzigddoorander_MGB_zv |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.224: | Regel 1.179: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigddoorander_MGB_zv (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MedicatiegebruikDatumTijd | ||
| + | |style="background-color: white;"|T - 3 dagen om 08:08 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|GebruikIndicator | ||
| + | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|VolgensAfspraakIndicator |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 60 dagen, tot en met T - 3 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 60 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 3 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| Regel 1.246: | Regel 1.207: | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#MARCHA_VAN_PARTNERS|Zorgverlener: MARCHA_VAN_PARTNERS]] | |style="background-color: white;"|Zie [[#MARCHA_VAN_PARTNERS|Zorgverlener: MARCHA_VAN_PARTNERS]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Informant | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|InformantIsPatient | ||
| + | |style="background-color: white;"|Ja | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Auteur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 1.258: | Regel 1.233: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"|1 maal per dag 1 stuk, | + | |style="background-color: white;"|1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_gewijzigddoorander_MGB_pat |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.277: | Regel 1.259: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigddoorander_MGB_pat (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|MedicatiegebruikDatumTijd |
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T om 08:08 uur |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|GebruikIndicator | ||
| + | |style="background-color: white;"|Ja | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|VolgensAfspraakIndicator | ||
| + | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 3 dagen, tot en met T - 1 dag'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 3 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| Regel 1.301: | Regel 1.286: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Auteur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|AuteurIsPatient |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 1.317: | Regel 1.306: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |} | + | |}<section end=MBH_MBH_300_gewijzigddoorander /><section begin=MBH_MBH_300_onderbroken /> |
| + | ====Medicamenteuze behandeling MBH_300_onderbroken ==== | ||
| + | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_onderbroken_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.343: | Regel 1.334: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - 153 dagen om | + | |style="background-color: white;"|T - 153 dagen om 08:06 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| Regel 1.359: | Regel 1.350: | ||
|style="background-color: white;"|T + 20 dagen | |style="background-color: white;"|T + 20 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#MARCHA_VAN_PARTNERS|Zorgverlener: MARCHA_VAN_PARTNERS]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |||
| − | |||
| − | |||
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.387: | Regel 1.375: | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="4"|MBH identificatie | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_onderbroken_MA_onderbreken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.406: | Regel 1.387: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_onderbroken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - 100 dagen om | + | |style="background-color: white;"|T - 100 dagen om 18:12 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| Regel 1.422: | Regel 1.403: | ||
|style="background-color: white;"|T - 100 dagen | |style="background-color: white;"|T - 100 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|MedicatieafspraakStopType |
|style="background-color: white;"|onderbroken (code = '385655000' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | |style="background-color: white;"|onderbroken (code = '385655000' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#MARCHA_VAN_PARTNERS|Zorgverlener: MARCHA_VAN_PARTNERS]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RedenWijzigenOfStaken | ||
| + | |style="background-color: white;"|verrichting gepland (code = '405613005' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |||
| − | |||
| − | |||
|style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.454: | Regel 1.435: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| − | |} | + | |} |
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_onderbroken_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.481: | Regel 1.453: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_onderbroken_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 153 dagen om 09:06 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 153 dagen, tot en met T + 20 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 153 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE CF TABLET 20MG (code = '1099469' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |colspan="5"|Gebruiksinstructie | + | |colspan="4"|Geneesmiddel - generiekere code |
| + | |style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
| Regel 1.522: | Regel 1.497: | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_onderbroken_TA_onderbreken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.534: | Regel 1.516: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_onderbroken_TA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 100 dagen om 19:12 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 153 dagen, tot en met T - 100 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 153 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 100 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ToedieningsafspraakStopType | ||
| + | |style="background-color: white;"|onderbroken (code = '385655000' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
| Regel 1.558: | Regel 1.543: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE CF TABLET 20MG (code = '1099469' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 1.574: | Regel 1.559: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| − | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_onderbroken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieToedieningsafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_onderbroken_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |} | + | |}<section end=MBH_MBH_300_onderbroken /><section begin=MBH_MBH_300_andermans1 /> |
| + | ====Medicamenteuze behandeling MBH_300_andermans1 ==== | ||
| + | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_andermans1_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.597: | Regel 1.591: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_andermans1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om | + | |style="background-color: white;"|T - 10 dagen om 18:05 uur |
| − | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
| − | + | |colspan="4"|Gebruiksperiode | |
| − | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T + 15 dagen'' | |
| − | |||
| − | |||
| − | |||
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 1.617: | Regel 1.605: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 15 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.651: | Regel 1.625: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"|1 maal per dag 1 stuk, | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| Regel 1.670: | Regel 1.637: | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_andermans1_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.677: | Regel 1.644: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_andermans1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T om 18: | + | |style="background-color: white;"|T - 10 dagen om 18:45 uur |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T'' | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T + 15 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
| Regel 1.697: | Regel 1.658: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 15 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="4"|Geneesmiddel - primaire code |
| + | |style="background-color: white;"|PANTOPRAZOL TEVA TABLET MSR 20MG (code = '2002914' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="4"|Geneesmiddel - generiekere code | |
| − | |||
| − | |||
| − | |colspan="4"|Geneesmiddel - | ||
|style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 1.724: | Regel 1.681: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_andermans1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| − | |} | + | |} |
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_andermans1_MGB_zv |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.752: | Regel 1.707: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_andermans1_MGB_zv (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MedicatiegebruikDatumTijd | ||
| + | |style="background-color: white;"|T om 08:08 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|GebruikIndicator | ||
| + | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|VolgensAfspraakIndicator |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 9 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Einddatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#JAN_VAN_HARTEN|Zorgverlener: JAN_VAN_HARTEN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Informant | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|InformantIsPatient | ||
| + | |style="background-color: white;"|Ja | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 1.776: | Regel 1.751: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 1.786: | Regel 1.761: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_andermans1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_andermans1_MGB_pat |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.805: | Regel 1.787: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_andermans1_MGB_pat (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MedicatiegebruikDatumTijd | ||
| + | |style="background-color: white;"|T om 18:08 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|GebruikIndicator | ||
| + | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|VolgensAfspraakIndicator |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen, tot en met T'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 9 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Einddatum | ||
| + | |style="background-color: white;"|T | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Voorschrijver | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#JAN_VAN_HARTEN|Zorgverlener: JAN_VAN_HARTEN]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|AuteurIsPatient |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 1.842: | Regel 1.834: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |}<section end= | + | |}<section end=MBH_MBH_300_andermans1 /><section begin=MBH_MBH_300_andermans2 /> |
| − | ====Medicamenteuze behandeling | + | ====Medicamenteuze behandeling MBH_300_andermans2 ==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_andermans2_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.870: | Regel 1.862: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_andermans2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 159 dagen om 08:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 159 dagen, gedurende 1 week'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 159 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Gebruiksduur | ||
| + | |style="background-color: white;"|1 week | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| Regel 1.888: | Regel 1.883: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#JAN_VAN_HARTEN|Zorgverlener: JAN_VAN_HARTEN]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 1.901: | Regel 1.896: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 1.907: | Regel 1.902: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_andermans2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_andermans2_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.920: | Regel 1.915: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_andermans2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 159 dagen om 09:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 159 dagen, gedurende 1 week'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 159 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Gebruiksduur |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 week |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Geneesmiddel - primaire code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|Geneesmiddel - | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 1.960: | Regel 1.952: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| − | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard ') | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_eigen2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_andermans2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |} | + | |}<section end=MBH_MBH_300_andermans2 /><section begin=MBH_MBH_300_geannuleerd /> |
| + | ====Medicamenteuze behandeling MBH_300_geannuleerd ==== | ||
| + | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_geannuleerd_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 1.986: | Regel 1.980: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_geannuleerd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - 2 dagen om | + | |style="background-color: white;"|T - 2 dagen om 18:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| Regel 1.999: | Regel 1.993: | ||
|style="background-color: white;"|T + 5 dagen | |style="background-color: white;"|T + 5 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#MARCHA_VAN_PARTNERS|Zorgverlener: MARCHA_VAN_PARTNERS]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |||
| − | |||
| − | |||
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.027: | Regel 2.018: | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| Regel 2.039: | Regel 2.023: | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_geannuleerd_MA_annuleren |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.046: | Regel 2.030: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_geannuleerd_MA_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - 1 dag om | + | |style="background-color: white;"|T - 1 dag om 15:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| Regel 2.062: | Regel 2.046: | ||
|style="background-color: white;"|T + 5 dagen om 00:00 uur | |style="background-color: white;"|T + 5 dagen om 00:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|MedicatieafspraakStopType |
|style="background-color: white;"|geannuleerd (code = '89925002' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | |style="background-color: white;"|geannuleerd (code = '89925002' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#MARCHA_VAN_PARTNERS|Zorgverlener: MARCHA_VAN_PARTNERS]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RedenWijzigenOfStaken |
|style="background-color: white;"|medicatiebeleid veranderd (code = '112751000146109' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | |style="background-color: white;"|medicatiebeleid veranderd (code = '112751000146109' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |||
| − | |||
| − | |||
|style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.092: | Regel 2.073: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| − | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard ') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|2 maal per dag 1 stuk | |style="background-color: white;"|2 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_geannuleerd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="4"|MBH identificatie | |
| − | + | |style="background-color: white;"|MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
| − | + | |} | |
| − | |||
| − | |||
| − | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"|MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| − | |} | ||
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_geannuleerd_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.124: | Regel 2.096: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_geannuleerd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen om 19:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 5 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 5 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_JANSEN_EN_CO|Zorgaanbieder: APOTHEEK_JANSEN_EN_CO]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 2.158: | Regel 2.130: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 2.164: | Regel 2.136: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 stuk |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_andermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_geannuleerd_TA_annuleren |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.177: | Regel 2.156: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_geannuleerd_TA_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - 1 dag om | + | |style="background-color: white;"|T - 1 dag om 16:45 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 5 dagen, tot en met T + 5 dagen om 00:00 uur'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 5 dagen om 00:00 uur |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ToedieningsafspraakStopType | ||
| + | |style="background-color: white;"|geannuleerd (code = '89925002' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
| Regel 2.198: | Regel 2.180: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgaanbieder | |colspan="3"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_JANSEN_EN_CO|Zorgaanbieder: APOTHEEK_JANSEN_EN_CO]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ToedieningsafspraakRedenWijzigenOfStaken | ||
| + | |style="background-color: white;"|medicatiebeleid veranderd (code = '112751000146109' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 2.214: | Regel 2.199: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 2.220: | Regel 2.205: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 stuk |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_geannuleerd_MA_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_geannuleerd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |}<section end= | + | |}<section end=MBH_MBH_300_geannuleerd /><section begin=MBH_MBH_300_toekomstig /> |
| − | ====Medicamenteuze behandeling | + | ====Medicamenteuze behandeling MBH_300_toekomstig ==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_toekomstig_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.242: | Regel 2.234: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toekomstig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag om 08:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 15 dagen, tot en met T + 51 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 15 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 51 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| Regel 2.266: | Regel 2.258: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DOXYCYCLINE 100MG TABLET (code = '19844' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DOXYCYCLINE 100MG TABLET (code = '22179' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 2.285: | Regel 2.277: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_toekomstig_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.295: | Regel 2.287: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toekomstig_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag om 09:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 15 dagen, tot en met T + 51 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 15 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 51 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Geneesmiddel - primaire code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DOXYCYCLINE PCH TABLET 100MG (code = '1141317' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|Geneesmiddel - | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DOXYCYCLINE 100MG TABLET (code = '19844' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DOXYCYCLINE 100MG TABLET (code = '22179' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 2.343: | Regel 2.332: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toekomstig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |} | + | |}<section end=MBH_MBH_300_toekomstig /><section begin=MBH_MBH_300_gestoptandermans /> |
| + | ====Medicamenteuze behandeling MBH_300_gestoptandermans ==== | ||
| + | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_gestoptandermans_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.361: | Regel 2.352: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - 20 dagen om | + | |style="background-color: white;"|T - 20 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| Regel 2.377: | Regel 2.368: | ||
|style="background-color: white;"|T + 7 dagen | |style="background-color: white;"|T + 7 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#MARCHA_VAN_PARTNERS|Zorgverlener: MARCHA_VAN_PARTNERS]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |||
| − | |||
| − | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.405: | Regel 2.393: | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| Regel 2.417: | Regel 2.398: | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_gestoptandermans_MA_staken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.424: | Regel 2.405: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gestoptandermans_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - 10 dagen om | + | |style="background-color: white;"|T - 10 dagen om 18:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| Regel 2.440: | Regel 2.421: | ||
|style="background-color: white;"|T - 10 dagen | |style="background-color: white;"|T - 10 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|MedicatieafspraakStopType |
|style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RedenWijzigenOfStaken | ||
| + | |style="background-color: white;"|geneesmiddelinteractie (code = '79899007' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |||
| − | |||
| − | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.472: | Regel 2.453: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| − | |} | + | |} |
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_gestoptandermans_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.499: | Regel 2.471: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gestoptandermans_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen om 09:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T + 7 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Einddatum | ||
| + | |style="background-color: white;"|T + 7 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_JANSEN_EN_CO|Zorgaanbieder: APOTHEEK_JANSEN_EN_CO]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 2.530: | Regel 2.508: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 2.536: | Regel 2.514: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|MBH identificatie | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_gestoptandermans_TA_staken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.549: | Regel 2.534: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gestoptandermans_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 19:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, tot en met T - 10 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 20 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Einddatum | ||
| + | |style="background-color: white;"|T - 10 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ToedieningsafspraakStopType | ||
| + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_JANSEN_EN_CO|Zorgaanbieder: APOTHEEK_JANSEN_EN_CO]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Geneesmiddel - primaire code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|Geneesmiddel - | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 2.583: | Regel 2.574: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 2.589: | Regel 2.580: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per dag 1 stuk |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_gestoptandermans_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gestoptandermans_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |} | + | |}<section end=MBH_MBH_300_gestoptandermans /><section begin=MBH_MBH_300_gewijzigd_toekomst /> |
| + | ====Medicamenteuze behandeling MBH_300_gewijzigd_toekomst ==== | ||
| + | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_gewijzigd_toekomst_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.609: | Regel 2.609: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 11 dagen om 08:20 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - 11 dagen | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 11 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - 11 dagen | |style="background-color: white;"|T - 11 dagen | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| Regel 2.653: | Regel 2.647: | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|2 maal per week 1 stuk | |style="background-color: white;"|2 maal per week 1 stuk | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| Regel 2.665: | Regel 2.652: | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_gewijzigd_toekomst_MA_wijziging |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.672: | Regel 2.659: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag om 08:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 2 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#MARCHA_VAN_PARTNERS|Zorgverlener: MARCHA_VAN_PARTNERS]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RedenWijzigenOfStaken | ||
| + | |style="background-color: white;"|te sterk effect van medicatie (code = '112251000146103' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |||
| − | |||
| − | |||
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.706: | Regel 2.693: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 2.712: | Regel 2.699: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per week 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 2.725: | Regel 2.712: | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_gewijzigd_toekomst_MA_techstaken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.732: | Regel 2.719: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - 1 dag om | + | |style="background-color: white;"|T - 1 dag om 08:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 11 dagen, tot en met T + 1 dag om 00:00 uur'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T + 2 | + | |style="background-color: white;"|T - 11 dagen |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |colspan="5"| | + | |colspan="3"|Einddatum |
| + | |style="background-color: white;"|T + 1 dag om 00:00 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MedicatieafspraakStopType | ||
| + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#MARCHA_VAN_PARTNERS|Zorgverlener: MARCHA_VAN_PARTNERS]] |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |||
| − | |||
| − | |||
|style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 2.769: | Regel 2.756: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per week 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| − | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per week 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| Regel 2.795: | Regel 2.775: | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_gewijzigd_toekomst_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.802: | Regel 2.782: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigd_toekomst_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 11 dagen om 10:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - 11 dagen | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 11 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - 11 dagen | |style="background-color: white;"|T - 11 dagen | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
| Regel 2.845: | Regel 2.819: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| − | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G- | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|2 maal per week 1 stuk | |style="background-color: white;"|2 maal per week 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| − | |} | + | |} |
| − | + | {| class="wikitable" width="85%" | |
| − | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_gewijzigd_toekomst_TA_wijziging | |
| − | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 2.877: | Regel 2.842: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigd_toekomst_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - 1 dag om | + | |style="background-color: white;"|T - 1 dag om 11:10 uur |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 2 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |colspan=" | + | |colspan="4"|ToedieningsafspraakRedenWijzigenOfStaken |
| + | |style="background-color: white;"|te sterk effect van medicatie (code = '112251000146103' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="4"|Geneesmiddel - generiekere code |
| + | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 2.915: | Regel 2.879: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per week 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per | + | |style="background-color: white;"|1 maal per week 1 stuk |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieToedieningsafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2.16.840.1.113883.2.4.3.11.999.77.16076005.1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|MBH identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | | | + | |} |
| − | |colspan="4"| | + | {| class="wikitable" width="85%" |
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_gewijzigd_toekomst_TA_techstaken | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="4"|Identificatie |
| + | |style="background-color: white;"|MBH_300_gewijzigd_toekomst_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 1 dag om 11:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Gebruiksperiode |
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 11 dagen, tot en met T + 1 dag om 00:00 uur'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 11 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Einddatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T + 1 dag om 00:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|ToedieningsafspraakStopType |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="4"|Geneesmiddel - primaire code |
| + | |style="background-color: white;"|FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Gebruiksinstructie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Omschrijving |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per week 1 stuk, Oraal |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Toedieningsweg | ||
| + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie | ||
| + | |style="background-color: white;"|2 maal per week 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigd_toekomst_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="4"|MBH identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_gewijzigd_toekomst_MTD1 | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigd_toekomst_MTD1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="4"|RegistratieDatumTijd |
| + | |style="background-color: white;"|T - 5 dagen om 08:14:44 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|ToedieningsDatumTijd |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 5 dagen om 08:14:44 uur |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|ToegediendeHoeveelheid |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Aantal |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Eenheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Toedieningsweg |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Toediener |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geneesmiddel - primaire code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieToedieningsafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="2"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigd_toekomst_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|MBH identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |} | + | |} |
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_gewijzigd_toekomst_MTD2 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_gewijzigd_toekomst_MTD2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T om 07:15:23 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ToedieningsDatumTijd | ||
| + | |style="background-color: white;"|T om 07:15:23 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|ToegediendeHoeveelheid |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Aantal |
| + | |style="background-color: white;"|1 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Eenheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Toedieningsweg |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Toediener |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Geneesmiddel - primaire code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') |
| − | |}<section end= | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | ====Medicamenteuze behandeling | + | |colspan="5"|RelatieMedicatieafspraak |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieToedieningsafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_gewijzigd_toekomst_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |}<section end=MBH_MBH_300_gewijzigd_toekomst /><section begin=MBH_MBH_300_gebruik /> | ||
| + | ====Medicamenteuze behandeling MBH_300_gebruik ==== | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_gebruik_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 3.103: | Regel 3.111: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gebruik_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MedicatiegebruikDatumTijd | ||
| + | |style="background-color: white;"|T - 1 dag om 08:12 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|GebruikIndicator |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen, tot en met T - 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Einddatum | ||
| + | |style="background-color: white;"|T - 2 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|AuteurIsPatient |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Geneesmiddel - ProductSpecificatie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="2"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|ProductNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Paracetamol 500mg |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 3.143: | Regel 3.158: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_gebruik (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |} | + | |}<section end=MBH_MBH_300_gebruik /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="JAN_VAN_HARTEN" title="Intern ID = JAN_VAN_HARTEN">Zorgverlener JAN_VAN_HARTEN</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="7"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|ZorgverlenerIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|000002222 (in identificerend systeem: UZI Personen) |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Naamgegevens |
| + | |style="background-color: white;"|Jan van Harten | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Specialisme |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Medisch specialisten, chirurgie (code = '0303' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgaanbieder | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="2"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Zorgaanbieder |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#ZIEKENHUIS_HET_GELE_HART|Zorgaanbieder: ZIEKENHUIS_HET_GELE_HART]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|<span id="JANTIEN_TOEDIEN" title="Intern ID = JANTIEN_TOEDIEN">Zorgverlener JANTIEN_TOEDIEN</span> |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|ZorgverlenerIdentificatienummer |
| + | |style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Naamgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Jantien Toedien |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Specialisme |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgaanbieder | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="2"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Zorgaanbieder |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#THUISZORG_OM_EN_BIJ|Zorgaanbieder: THUISZORG_OM_EN_BIJ]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|<span id="MARCHA_VAN_PARTNERS" title="Intern ID = MARCHA_VAN_PARTNERS">Zorgverlener MARCHA_VAN_PARTNERS</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|000001115 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Naamgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Marcha van Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Specialisme |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Zorgaanbieder |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_ITIS|Zorgaanbieder: HUISARTSENPRAKTIJK_ITIS]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="PETER_VAN_PULVER" title="Intern ID = PETER_VAN_PULVER">Zorgverlener PETER_VAN_PULVER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="7"| |
| − | |style=" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | + | |colspan="3"|ZorgverlenerIdentificatienummer | |
| − | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |
| − | |||
| − | | | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Naamgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Peter van Pulver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Specialisme |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Zorgaanbieder |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Zorgaanbieder |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|OrganisatieNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Adresgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|<span id="APOTHEEK_JANSEN_EN_CO" title="Intern ID = APOTHEEK_JANSEN_EN_CO">Zorgaanbieder APOTHEEK_JANSEN_EN_CO</span> |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
| + | |style="background-color: white;"|99901111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek Jansen en Co |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_ITIS" title="Intern ID = HUISARTSENPRAKTIJK_ITIS">Zorgaanbieder HUISARTSENPRAKTIJK_ITIS</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="4"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|00005111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|OrganisatieNaam |
| − | + | |style="background-color: white;"|Huisartsenpraktijk Itis | |
| − | |||
| − | |||
| − | |||
| − | | | ||
| − | | | ||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Adresgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Langelaan 1 1234ZZ Onze Stad |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|OrganisatieNaam |
| + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Adresgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|<span id="THUISZORG_OM_EN_BIJ" title="Intern ID = THUISZORG_OM_EN_BIJ">Zorgaanbieder THUISZORG_OM_EN_BIJ</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|11110000 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Thuiszorg Om en Bij |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieType |
| − | |style="background-color: white;"|1 | + | |style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|<span id="ZIEKENHUIS_HET_GELE_HART" title="Intern ID = ZIEKENHUIS_HET_GELE_HART">Zorgaanbieder ZIEKENHUIS_HET_GELE_HART</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="5"| |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|00004444 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Ziekenhuis het Gele Hart |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Adresgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Groenestraat 1 1200AA Hartstad |
| − | |} | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| + | |colspan="3"|OrganisatieType | ||
| + | |style="background-color: white;"|Ziekenhuis (code = 'V4' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | ||
| + | |}<section end=ALLMBHS_XXX_Rover /> | ||
| + | ==Patiënt J XXX_Vriends== | ||
| + | <section begin=XXX_Vriends /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Naamgegevens |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Initialen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|J |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Naamgebruik |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geslachtsnaam |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Achternaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Vriends |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Identificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999909216 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Geboortedatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Geslacht |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| + | |}<section end=XXX_Vriends /><section begin=ALLMBHS_XXX_Vriends /><section begin=MBH_MBH_300_NieuweMA /> | ||
| + | ====Medicamenteuze behandeling MBH_300_NieuweMA ==== | ||
| + | |||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_NieuweMA_start_MA | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|Geneesmiddel - generiekere code | + | |colspan="4"|Identificatie |
| + | |style="background-color: white;"|MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T - 289 dagen om 11:30 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksperiode | ||
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 289 dagen'' | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Ingangsdatum | ||
| + | |style="background-color: white;"|T - 289 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Voorschrijver | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.379: | Regel 3.408: | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| Regel 3.398: | Regel 3.413: | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_NieuweMA_stop_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 3.405: | Regel 3.420: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_NieuweMA_stop_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 70 dagen om 13:45 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 289 dagen, tot en met T - 71 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 289 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Einddatum | ||
| + | |style="background-color: white;"|T - 71 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MedicatieafspraakStopType | ||
| + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RedenWijzigenOfStaken | ||
| + | |style="background-color: white;"|medicatiebeleid veranderd (code = '112751000146109' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |||
| − | |||
| − | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.447: | Regel 3.468: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| Regel 3.458: | Regel 3.479: | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_NieuweMA_nieuw_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 3.465: | Regel 3.486: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 30 dagen om 10:45 uur |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 30 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 3.503: | Regel 3.507: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |||
| − | |||
| − | |||
|style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.523: | Regel 3.524: | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| Regel 3.535: | Regel 3.529: | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_NieuweMA_start_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 3.542: | Regel 3.536: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_NieuweMA_start_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 289 dagen om 11:31 uur |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 289 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 289 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| Regel 3.601: | Regel 3.578: | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| − | |} | + | |} |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_NieuweMA_stop_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_NieuweMA_stop_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T - 25 dagen om 15:55 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Gebruiksperiode |
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 289 dagen, tot en met T - 71 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 289 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Einddatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 71 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|ToedieningsafspraakStopType |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="4"|ToedieningsafspraakRedenWijzigenOfStaken |
| + | |style="background-color: white;"|medicatiebeleid veranderd (code = '112751000146109' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geneesmiddel - primaire code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Omschrijving |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Toedieningsweg |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Doseerinstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_NieuweMA_stop_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_NieuweMA_start_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="4"|MBH identificatie | |
| − | + | |style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
| − | + | |} | |
| − | |colspan="4"| | ||
| − | |style="background-color: white;"| | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |} | ||
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_NieuweMA_nieuw_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 3.712: | Regel 3.672: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_NieuweMA_nieuw_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 25 dagen om 15:57 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - 30 | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - 30 dagen | |style="background-color: white;"|T - 30 dagen | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 3.746: | Regel 3.706: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 3.752: | Regel 3.712: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_NieuweMA_start_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 3.765: | Regel 3.732: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_NieuweMA_start_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MedicatiegebruikDatumTijd | ||
| + | |style="background-color: white;"|T - 289 dagen om 11:32 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|GebruikIndicator |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 289 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 289 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Informant | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|InformantIsPatient | ||
| + | |style="background-color: white;"|Ja | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Auteur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 3.802: | Regel 3.783: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 3.808: | Regel 3.789: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_NieuweMA_start_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_NieuweMA_nieuw_MGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 3.828: | Regel 3.809: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_NieuweMA_nieuw_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|MedicatiegebruikDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 13:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|GebruikIndicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 30 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Voorschrijver | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Informant | |colspan="5"|Informant | ||
| Regel 3.851: | Regel 3.836: | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|InformantIsPatient |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 3.862: | Regel 3.847: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 3.882: | Regel 3.867: | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|1 maal per dag 1 stuk | |style="background-color: white;"|1 maal per dag 1 stuk | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieToedieningsafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|MBH identificatie | + | |rowspan="2"| |
| − | |style="background-color: white;"| | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_NieuweMA_nieuw_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_NieuweMA_MTD1 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 3.894: | Regel 3.886: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_NieuweMA_MTD1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 2 dagen om 09:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToedieningsDatumTijd |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 2 dagen om 09:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|ToegediendeHoeveelheid |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Aantal |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Eenheid |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="4"|Toedieningsweg |
| − | | | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
| − | |||
| − | | | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Toediener |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"|3 | + | |style="background-color: white;"|MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieToedieningsafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="2"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"|3 | + | |style="background-color: white;"|MBH_300_NieuweMA_nieuw_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_NieuweMA_MTD2 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 3.960: | Regel 3.948: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_NieuweMA_MTD2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag om 10:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToedieningsDatumTijd |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 1 dag om 10:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|ToegediendeHoeveelheid |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Aantal |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Eenheid | ||
| + | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Toedieningsweg |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Toediener |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"|1 | + | |style="background-color: white;"|MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieToedieningsafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="2"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"|1 | + | |style="background-color: white;"|MBH_300_NieuweMA_nieuw_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_NieuweMA_MTD3 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 4.026: | Regel 4.010: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_NieuweMA_MTD3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 1 dag om 10:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|ToedieningsDatumTijd |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 1 dag om 10:10 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|ToegediendeHoeveelheid |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Aantal |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|-1 |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Eenheid | ||
| + | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Toedieningsweg |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Toediener |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MedicatietoedieningRedenVanAfwijken | ||
| + | |style="background-color: white;"|medicatie uitgespuugd door patiënt (code = '152741000146103' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieToedieningsafspraak |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_NieuweMA_nieuw_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_NieuweMA_MTD4 | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_NieuweMA_MTD4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T - 1 dag om 11:30 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ToedieningsDatumTijd | ||
| + | |style="background-color: white;"|T - 1 dag om 11:30 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|ToegediendeHoeveelheid | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Aantal | ||
| + | |style="background-color: white;"|1 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Eenheid | ||
| + | |style="background-color: white;"|stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Toedieningsweg | ||
| + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Toediener | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_NieuweMA_nieuw_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |}<section end= | + | |}<section end=MBH_MBH_300_NieuweMA /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | ||
| Regel 4.105: | Regel 4.136: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"|<span id=" | + | |colspan="5"|<span id="JANTIEN_TOEDIEN" title="Intern ID = JANTIEN_TOEDIEN">Zorgverlener JANTIEN_TOEDIEN</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgegevens | |colspan="3"|Naamgegevens | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Jantien Toedien |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Specialisme | |colspan="3"|Specialisme | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Zorgaanbieder | |colspan="4"|Zorgaanbieder | ||
| Regel 4.123: | Regel 4.154: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#THUISZORG_OM_EN_BIJ|Zorgaanbieder: THUISZORG_OM_EN_BIJ]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | + | |colspan="5"|<span id="PETER_VAN_PULVER" title="Intern ID = PETER_VAN_PULVER">Zorgverlener PETER_VAN_PULVER</span> |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgverlenerIdentificatienummer | ||
| + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgegevens | ||
| + | |style="background-color: white;"|Peter van Pulver | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Specialisme | ||
| + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 4.142: | Regel 4.193: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Adresgegevens | |colspan="3"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
| − | |}<section end= | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | ==Patiënt J van | + | |colspan="5"|<span id="THUISZORG_OM_EN_BIJ" title="Intern ID = THUISZORG_OM_EN_BIJ">Zorgaanbieder THUISZORG_OM_EN_BIJ</span> |
| − | <section begin= | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|11110000 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Thuiszorg Om en Bij | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|OrganisatieType | ||
| + | |style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') | ||
| + | |}<section end=ALLMBHS_XXX_Vriends /> | ||
| + | ==Patiënt J van de XXX_Lans== | ||
| + | <section begin=XXX_Lans /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 4.175: | Regel 4.239: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Voorvoegsels | |colspan="2"|Voorvoegsels | ||
| − | |style="background-color: white;"|van | + | |style="background-color: white;"|van de |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Lans |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999909228 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| Regel 4.187: | Regel 4.251: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end= | + | |}<section end=XXX_Lans /><section begin=ALLMBHS_XXX_Lans /><section begin=MBH_MBH_300_OTCmedicatie /> |
| − | ====Medicamenteuze behandeling | + | ====Medicamenteuze behandeling MBH_300_OTCmedicatie ==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_OTCmedicatie_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 4.199: | Regel 4.263: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_OTCmedicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 30 dagen om 10:45 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen, tot en met T - 16 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 30 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Einddatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 16 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| Regel 4.223: | Regel 4.287: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 4.233: | Regel 4.297: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"|2 maal per dag | + | |style="background-color: white;"|2 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 4.239: | Regel 4.303: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"|2 maal per dag | + | |style="background-color: white;"|2 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_OTCmedicatie_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 4.252: | Regel 4.316: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_OTCmedicatie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 28 dagen om 14:35 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 28 dagen, tot en met T - 14 dagen om 00:00 uur'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 28 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Einddatum | ||
| + | |style="background-color: white;"|T - 14 dagen om 00:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 4.283: | Regel 4.353: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 4.289: | Regel 4.359: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 stuk |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_OTCmedicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_OTCmedicatie_MGB_oud1 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 4.302: | Regel 4.379: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_OTCmedicatie_MGB_oud1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MedicatiegebruikDatumTijd | ||
| + | |style="background-color: white;"|T - 270 dagen om 16:03 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|GebruikIndicator |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 280 dagen, tot en met T - 273 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 280 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 273 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Informant | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|InformantIsPatient |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 4.329: | Regel 4.413: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 4.339: | Regel 4.426: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 4.345: | Regel 4.432: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_OTCmedicatie_MGB_oud2 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 4.365: | Regel 4.445: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_OTCmedicatie_MGB_oud2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MedicatiegebruikDatumTijd | ||
| + | |style="background-color: white;"|T - 150 dagen om 11:59 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|GebruikIndicator |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 155 dagen, tot en met T - 147 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 155 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 147 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Informant | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|InformantIsPatient | ||
| + | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 4.389: | Regel 4.479: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 4.399: | Regel 4.492: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 4.405: | Regel 4.498: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_OTCmedicatie_MGB_oud3 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 4.425: | Regel 4.511: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_OTCmedicatie_MGB_oud3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MedicatiegebruikDatumTijd | ||
| + | |style="background-color: white;"|T - 29 dagen om 09:22 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|GebruikIndicator |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 80 dagen, tot en met T - 75 dagen'' |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Ingangsdatum | ||
| + | |style="background-color: white;"|T - 80 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Einddatum | ||
| + | |style="background-color: white;"|T - 75 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Informant | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|InformantIsPatient |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 4.459: | Regel 4.558: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 4.465: | Regel 4.564: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="4"|MBH identificatie | |
| − | + | |style="background-color: white;"|MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
| − | |||
| − | |||
| − | |||
| − | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_OTCmedicatie_MGB_nieuw |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 4.485: | Regel 4.577: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_OTCmedicatie_MGB_nieuw (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MedicatiegebruikDatumTijd | ||
| + | |style="background-color: white;"|T - 16 dagen om 14:45 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|GebruikIndicator |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 28 dagen, tot en met T - 14 dagen'' |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Ingangsdatum | ||
| + | |style="background-color: white;"|T - 28 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Einddatum | ||
| + | |style="background-color: white;"|T - 14 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Voorschrijver | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Informant | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|InformantIsPatient |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 4.519: | Regel 4.631: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 4.525: | Regel 4.637: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_OTCmedicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |} | + | |}<section end=MBH_MBH_300_OTCmedicatie /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|<span id="PETER_VAN_PULVER" title="Intern ID = PETER_VAN_PULVER">Zorgverlener PETER_VAN_PULVER</span> |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Naamgegevens |
| + | |style="background-color: white;"|Peter van Pulver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Specialisme |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|OrganisatieNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Adresgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Adresgegevens |
| − | |style="background-color: white;"|2 | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
| + | |}<section end=ALLMBHS_XXX_Lans /> | ||
| + | ==Patiënt J van XXX_Noort== | ||
| + | <section begin=XXX_Noort /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Naamgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Initialen | ||
| + | |style="background-color: white;"|J | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgebruik | ||
| + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geslachtsnaam |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Voorvoegsels | ||
| + | |style="background-color: white;"|van | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Achternaam | ||
| + | |style="background-color: white;"|XXX_Noort | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="4"|Identificatienummer |
| + | |style="background-color: white;"|999909241 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geboortedatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Geslacht |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |} | + | |}<section end=XXX_Noort /><section begin=ALLMBHS_XXX_Noort /><section begin=MBH_MBH_300_ToekomstigEnNieuweMA /> |
| + | ====Medicamenteuze behandeling MBH_300_ToekomstigEnNieuweMA ==== | ||
| + | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_startMA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 4.622: | Regel 4.750: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 98 dagen om 15:11 uur |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 98 dagen, gedurende 50 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 98 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Gebruiksduur | ||
| + | |style="background-color: white;"|50 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 4.660: | Regel 4.774: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |||
| − | |||
| − | |||
|style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 4.673: | Regel 4.784: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 4.679: | Regel 4.790: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 2 stuks |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| − | |} | + | |} |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_ToekomstMA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="4"|Identificatie |
| + | |style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_ToekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 70 dagen om 14:44 uur |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksperiode | ||
| + | |style="background-color: #E3E3E3;;"|''Vanaf T + 10 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="2"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T + 10 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="4"|Geneesmiddel - primaire code |
| + | |style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Omschrijving |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk, oraal |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Toedieningsweg | ||
| + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Doseerinstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|MBH identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |} | + | |} |
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_stopMA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T - 63 dagen om 09:13 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Gebruiksperiode |
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 98 dagen, tot en met T - 63 dagen'' | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Ingangsdatum |
| + | |style="background-color: white;"|T - 98 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Einddatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 63 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|MedicatieafspraakStopType |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Gebruiksinstructie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Omschrijving | ||
| + | |style="background-color: white;"|2 maal per dag 2 stuks, oraal | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Toedieningsweg | ||
| + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie | ||
| + | |style="background-color: white;"|2 maal per dag 2 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="2"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|MBH identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |} | + | |} |
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_NieuwMA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 4.789: | Regel 4.916: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_NieuwMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 63 dagen om 09:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 30 dagen, tot en met T + 9 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 30 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Einddatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T + 9 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| Regel 4.813: | Regel 4.940: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 4.823: | Regel 4.950: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"|gedurende | + | |style="background-color: white;"|gedurende 39 dagen 2 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 4.829: | Regel 4.956: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"|gedurende | + | |style="background-color: white;"|gedurende 39 dagen 2 maal per dag 1 stuk |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_ToekomstigEnNieuweMA_startTA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 4.842: | Regel 4.976: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 98 dagen om 15:15 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 98 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 98 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 4.876: | Regel 5.010: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 4.882: | Regel 5.016: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 2 stuks |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_ToekomstigEnNieuweMA_ToekomstTA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 4.895: | Regel 5.036: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_ToekomstTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 70 dagen om 14:45 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 10 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 10 dagen |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 4.932: | Regel 5.070: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 4.938: | Regel 5.076: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_ToekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_ToekomstigEnNieuweMA_startMGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 4.958: | Regel 5.096: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MedicatiegebruikDatumTijd | ||
| + | |style="background-color: white;"|T - 98 dagen om 15:20 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|GebruikIndicator |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 98 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 98 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| Regel 4.980: | Regel 5.118: | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Informant | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="2"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Auteur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|Geneesmiddel - generiekere code | + | |rowspan="2"| |
| − | |style="background-color: white;"| | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| + | |colspan="3"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 4.995: | Regel 5.147: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 5.001: | Regel 5.153: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|2 maal per dag 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_ToekomstigEnNieuweMA_ToekomstMGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 5.021: | Regel 5.173: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_ToekomstMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MedicatiegebruikDatumTijd | ||
| + | |style="background-color: white;"|T - 70 dagen om 14:50 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|GebruikIndicator |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 10 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T + 10 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Voorschrijver | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Informant | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 5.058: | Regel 5.224: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 5.064: | Regel 5.230: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA_ToekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |} | + | |}<section end=MBH_MBH_300_ToekomstigEnNieuweMA /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="PETER_VAN_PULVER" title="Intern ID = PETER_VAN_PULVER">Zorgverlener PETER_VAN_PULVER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="7"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|ZorgverlenerIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Naamgegevens |
| + | |style="background-color: white;"|Peter van Pulver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Specialisme |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|OrganisatieNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Adresgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
| + | |}<section end=ALLMBHS_XXX_Noort /> | ||
| + | ==Patiënt j XXX_Schoutens== | ||
| + | <section begin=XXX_Schoutens /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Naamgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="6"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Initialen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|j |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Naamgebruik |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geslachtsnaam |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Achternaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Schoutens |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatienummer | ||
| + | |style="background-color: white;"|999909253 [BSN] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geboortedatum | ||
| + | |style="background-color: white;"|18 sep 1963 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Geslacht |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |} | + | |}<section end=XXX_Schoutens /><section begin=ALLMBHS_XXX_Schoutens /><section begin=MBH_MBH_300_nieuweToekomstigeMA /> |
| + | ====Medicamenteuze behandeling MBH_300_nieuweToekomstigeMA ==== | ||
| + | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_nieuweToekomstigeMA_startMA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 5.147: | Regel 5.340: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_nieuweToekomstigeMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - 20 dagen om 10: | + | |style="background-color: white;"|T - 20 dagen om 10:01 uur |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| Regel 5.172: | Regel 5.362: | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="4"|Geneesmiddel - primaire code | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |colspan="4"|Geneesmiddel - primaire | ||
| − | |||
| − | |||
| − | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.208: | Regel 5.381: | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|gedurende 3 weken 1 maal per dag 1 stuk | |style="background-color: white;"|gedurende 3 weken 1 maal per dag 1 stuk | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| Regel 5.220: | Regel 5.386: | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_nieuweToekomstigeMA_toekomstMA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 5.227: | Regel 5.393: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - 15 dagen om 13: | + | |style="background-color: white;"|T - 15 dagen om 13:26 uur |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| Regel 5.247: | Regel 5.410: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 5.268: | Regel 5.417: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |||
| − | |||
| − | |||
|style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.288: | Regel 5.434: | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
|style="background-color: white;"|gedurende 1 week 1 maal per dag 3 stuks | |style="background-color: white;"|gedurende 1 week 1 maal per dag 3 stuks | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
|style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| − | |} | + | |} |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_nieuweToekomstigeMA_annuleerMA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |colspan="4"|Identificatie |
| + | |style="background-color: white;"|MBH_300_nieuweToekomstigeMA_annuleerMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T - 5 dagen om 15:15 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksperiode | ||
| + | |style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, tot en met T + 1 dag om 00:00 uur'' | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T + 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Einddatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T + 1 dag om 00:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|MedicatieafspraakStopType |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|geannuleerd (code = '89925002' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Omschrijving |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|gedurende 1 week 1 maal per dag 3 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Toedieningsweg |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Doseerinstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|gedurende 1 week 1 maal per dag 3 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|MBH identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | + | |} | |
| − | |||
| − | |||
| − | |} | ||
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_nieuweToekomstigeMA_nieuwMA | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | ||
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 5.400: | Regel 5.509: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_nieuweToekomstigeMA_nieuwMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - 5 dagen om | + | |style="background-color: white;"|T - 5 dagen om 15:20 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, gedurende 4 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Gebruiksduur |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|4 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| Regel 5.425: | Regel 5.531: | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
|style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RedenWijzigenOfStaken | ||
| + | |style="background-color: white;"|foutieve registratie van medicatie (code = '159691000146109' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 5.437: | Regel 5.546: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|gedurende 4 dagen 1 maal per dag 2 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per dag 1 | + | |style="background-color: white;"|gedurende 4 dagen 1 maal per dag 2 stuks |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_nieuweToekomstigeMA_startTA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 5.456: | Regel 5.572: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_nieuweToekomstigeMA_startTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen om 10:05 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 3 weken'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Gebruiksduur |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 weken |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 5.490: | Regel 5.609: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"|1 maal per dag 1 | + | |style="background-color: white;"|gedurende 3 weken 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 5.496: | Regel 5.615: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per dag 1. | + | |style="background-color: white;"|gedurende 3 weken 1 maal per dag 1 stuk |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_nieuweToekomstigeMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_nieuweToekomstigeMA_toekomstTA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 5.509: | Regel 5.635: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 15 dagen om 13:30 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T + | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, gedurende 1 week'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Gebruiksduur | |colspan="3"|Gebruiksduur | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 week |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 5.543: | Regel 5.672: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|gedurende 1 week 1 maal per dag 3 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 5.549: | Regel 5.678: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per dag 1 | + | |style="background-color: white;"|gedurende 1 week 1 maal per dag 3 stuks |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_nieuweToekomstigeMA_startMGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 5.562: | Regel 5.698: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_nieuweToekomstigeMA_startMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MedicatiegebruikDatumTijd | ||
| + | |style="background-color: white;"|T - 20 dagen om 10:10 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|GebruikIndicator |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen, gedurende 3 weken'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Gebruiksduur |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|3 weken |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Informant | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|InformantIsPatient | ||
| + | |style="background-color: white;"|Ja | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Auteur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 5.599: | Regel 5.752: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"|1 maal per dag 1 stuk, oraal | + | |style="background-color: white;"|gedurende 3 weken 1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 5.605: | Regel 5.758: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per dag 1 stuk | + | |style="background-color: white;"|gedurende 3 weken 1 maal per dag 1 stuk |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_nieuweToekomstigeMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_nieuweToekomstigeMA_toekomstMGB |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 5.618: | Regel 5.778: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|MedicatiegebruikDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 15 dagen om 13:35 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|GebruikIndicator |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 1 dag, gedurende 1 week'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 1 dag |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Gebruiksduur |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 week |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| Regel 5.648: | Regel 5.808: | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|InformantIsPatient |
|style="background-color: white;"|Ja | |style="background-color: white;"|Ja | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.659: | Regel 5.819: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 5.672: | Regel 5.832: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|gedurende 1 week 1 maal per dag 3 stuks, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 5.678: | Regel 5.838: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie | |colspan="3"|Doseerinstructie | ||
| − | |style="background-color: white;"|1 maal per dag | + | |style="background-color: white;"|gedurende 1 week 1 maal per dag 3 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |}<section end= | + | |}<section end=MBH_MBH_300_nieuweToekomstigeMA /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | ||
| Regel 5.701: | Regel 5.861: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.721: | Regel 5.881: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 5.734: | Regel 5.894: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00001111 (in identificerend systeem: URA) | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Adresgegevens | |colspan="3"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
| − | |}<section end= | + | |}<section end=ALLMBHS_XXX_Schoutens /> |
| − | ==Patiënt | + | ==Patiënt J de XXX_Groote== |
| − | <section begin= | + | <section begin=XXX_Groote /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 5.754: | Regel 5.914: | ||
|colspan="5"|Naamgegevens | |colspan="5"|Naamgegevens | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|J |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 5.764: | Regel 5.924: | ||
|colspan="4"|Geslachtsnaam | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan="2"| | + | |rowspan="3"| |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Voorvoegsels | ||
| + | |style="background-color: white;"|de | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Groote |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999909265 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| Regel 5.776: | Regel 5.939: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end= | + | |}<section end=XXX_Groote /><section begin=ALLMBHS_XXX_Groote /><section begin=MBH_MBH_300_stopMA_zonder_referentie /> |
| − | ====Medicamenteuze behandeling | + | ====Medicamenteuze behandeling MBH_300_stopMA_zonder_referentie ==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_stopMA_zonder_referentie_stopMA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 5.788: | Regel 5.951: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stopMA_zonder_referentie_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - 5 dagen om | + | |style="background-color: white;"|T - 5 dagen om 13:55 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T - 5 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - 5 dagen | + | |style="background-color: white;"|T - 14 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Einddatum | ||
| + | |style="background-color: white;"|T - 5 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MedicatieafspraakStopType | ||
| + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| Regel 5.806: | Regel 5.975: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 5.819: | Regel 5.988: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Doseerinstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_stopMA_zonder_referentie_startMA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 5.838: | Regel 6.007: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stopMA_zonder_referentie_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - 5 dagen om | + | |style="background-color: white;"|T - 5 dagen om 13:57 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen, tot en met T + 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - 5 dagen | + | |style="background-color: white;"|T - 5 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
|style="background-color: white;"|T + 2 dagen | |style="background-color: white;"|T + 2 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1.5 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"|Doseerinstructie | + | |colspan="3"|Doseerinstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1.5 stuk |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_stopMA_zonder_referentie_toekomstMA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 5.910: | Regel 6.060: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stopMA_zonder_referentie_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - 5 dagen om | + | |style="background-color: white;"|T - 5 dagen om 14:03 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 3 dagen, gedurende 3 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T + 3 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Gebruiksduur | ||
| + | |style="background-color: white;"|3 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - generiekere code | |colspan="4"|Geneesmiddel - generiekere code | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
| Regel 5.944: | Regel 6.094: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Doseerinstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |} | + | |} |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_stopMA_zonder_referentie_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_stopMA_zonder_referentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T - 14 dagen om 15:14 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Gebruiksperiode |
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T + 2 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 14 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Einddatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T + 2 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="4"|Geneesmiddel - primaire code |
| + | |style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |
| − | |||
| − | |||
| − | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="5"|Gebruiksinstructie | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |colspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Omschrijving |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk, oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Toedieningsweg |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Doseerinstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|1 maal per dag 1 stuk |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="4"|MBH identificatie |
| + | |style="background-color: white;"|MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatiegebruik MBH_300_stopMA_zonder_referentie_MGB | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_stopMA_zonder_referentie_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|MedicatiegebruikDatumTijd |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 14 dagen om 15:20 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|GebruikIndicator |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Gebruiksperiode |
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 14 dagen, tot en met T + 2 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 14 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Einddatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T + 2 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Voorschrijver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="2"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | | | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Informant |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|InformantIsPatient |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Ja |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Geneesmiddel - primaire code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') |
| − | |}<section end= | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | + | |colspan="5"|Gebruiksinstructie | |
| − | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Omschrijving | ||
| + | |style="background-color: white;"|1 maal per dag 1 stuk, oraal | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Toedieningsweg | ||
| + | |style="background-color: white;"|oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie | ||
| + | |style="background-color: white;"|1 maal per dag 1 stuk | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieToedieningsafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_stopMA_zonder_referentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |}<section end=MBH_MBH_300_stopMA_zonder_referentie /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="PETER_VAN_PULVER" title="Intern ID = PETER_VAN_PULVER">Zorgverlener PETER_VAN_PULVER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="7"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|ZorgverlenerIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Naamgegevens |
| + | |style="background-color: white;"|Peter van Pulver | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Specialisme |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Adresgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
| − | |} | + | |}<section end=ALLMBHS_XXX_Groote /> |
| + | ==Patiënt H XXX_Snijdewint== | ||
| + | <section begin=XXX_Snijdewint /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Naamgegevens |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Initialen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|H |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Naamgebruik |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geslachtsnaam |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Achternaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Snijdewint |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Identificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999909125 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Geboortedatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="4"|Geslacht | |
| − | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |
| − | |colspan=" | + | |}<section end=XXX_Snijdewint /><section begin=ALLMBHS_XXX_Snijdewint /><section begin=MBH_MBH_300_WDS /> |
| − | + | ====Medicamenteuze behandeling MBH_300_WDS ==== | |
| − | + | ||
| − | |||
| − | |style="background-color: white;"| | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | | | ||
| − | |||
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_WDS_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 6.215: | Regel 6.339: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T - 5 dagen om 08:00 uur | |style="background-color: white;"|T - 5 dagen om 08:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen om 08:00 uur | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen om 08:00 uur'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
|style="background-color: white;"|T - 5 dagen om 08:00 uur | |style="background-color: white;"|T - 5 dagen om 08:00 uur | ||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#MARCHA_VAN_PARTNERS|Zorgverlener: MARCHA_VAN_PARTNERS]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| Regel 6.246: | Regel 6.367: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Volgens schema trombosedienst, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|AanvullendeInstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="4"|MBH identificatie | |
| − | + | |style="background-color: white;"|MBH_300_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | WisselendDoseerschema MBH_300_WDS_WDS |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 6.290: | Regel 6.389: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen om 08:00 uur, tot en met T + 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen om 08:00 uur |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Einddatum | ||
| + | |style="background-color: white;"|T + 2 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#TANJA_DE_BAKKER|Zorgverlener: TANJA_DE_BAKKER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |||
| − | |||
| − | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.321: | Regel 6.420: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="8"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|eerst gedurende 2 dagen 1 maal per dag 1 stuk, dan gedurende 1 dag 1 maal per dag 2 stuks, dan gedurende 2 dagen 1 maal per dag 1 stuk, dan gedurende 1 dag 1 maal per dag 2 stuks, dan gedurende 1 dag 1 maal per dag 1 stuk, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Doseerinstructie 1 |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|eerst gedurende 2 dagen 1 maal per dag 1 stuk |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Doseerinstructie 2 |
| + | |style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 2 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"|Identificatie | + | |colspan="3"|Doseerinstructie 3 |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|dan gedurende 2 dagen 1 maal per dag 1 stuk |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie 4 | ||
| + | |style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 2 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie 5 | ||
| + | |style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 1 stuk | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |} | + | |} |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_WDS_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="4"|Identificatie |
| + | |style="background-color: white;"|MBH_300_WDS_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 5 dagen om 08:00 uur |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksperiode | ||
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen om 08:00 uur'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="2"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 5 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="4"|Geneesmiddel - primaire code |
| + | |style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"|Naamgegevens | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"|Tanja de Bakker | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |colspan="3"|Specialisme | + | |colspan="5"|Gebruiksinstructie |
| − | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Omschrijving | ||
| + | |style="background-color: white;"|Volgens schema trombosedienst, Oraal | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Toedieningsweg | ||
| + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|AanvullendeInstructie | ||
| + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |}<section end=MBH_MBH_300_WDS /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="MARCHA_VAN_PARTNERS" title="Intern ID = MARCHA_VAN_PARTNERS">Zorgverlener MARCHA_VAN_PARTNERS</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgverlenerIdentificatienummer | ||
| + | |style="background-color: white;"|000001115 (in identificerend systeem: UZI Personen) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgegevens | ||
| + | |style="background-color: white;"|Marcha van Partners | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Specialisme | ||
| + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_ITIS|Zorgaanbieder: HUISARTSENPRAKTIJK_ITIS]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="TANJA_DE_BAKKER" title="Intern ID = TANJA_DE_BAKKER">Zorgverlener TANJA_DE_BAKKER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgverlenerIdentificatienummer | ||
| + | |style="background-color: white;"|222221111 (in identificerend systeem: UZI Personen) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgegevens | ||
| + | |style="background-color: white;"|Tanja de Bakker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Specialisme | ||
| + | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Zorgaanbieder | |colspan="4"|Zorgaanbieder | ||
| Regel 6.393: | Regel 6.564: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.406: | Regel 6.577: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00005111 (in identificerend systeem: URA) | |style="background-color: white;"|00005111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Itis | |style="background-color: white;"|Huisartsenpraktijk Itis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.419: | Regel 6.590: | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|11112222 (in identificerend systeem: URA) | |style="background-color: white;"|11112222 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Trombosedienst Ons Dorp | |style="background-color: white;"|Trombosedienst Ons Dorp | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|AfdelingSpecialisme |
|style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Adresgegevens | |colspan="3"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Kerkstraat 28 d 1332GH Ons Dorp | |style="background-color: white;"|Werkadres: Kerkstraat 28 d 1332GH Ons Dorp | ||
| − | |}<section end= | + | |}<section end=ALLMBHS_XXX_Snijdewint /> |
| − | ==Patiënt | + | ==Patiënt H XXX_Hulsing== |
| − | <section begin= | + | <section begin=XXX_Hulsing /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 6.445: | Regel 6.616: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|H |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 6.455: | Regel 6.626: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Hulsing |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999909137 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| Regel 6.465: | Regel 6.636: | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
|style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| − | |}<section end= | + | |}<section end=XXX_Hulsing /><section begin=ALLMBHS_XXX_Hulsing /><section begin=MBH_MBH_300_WDS_nieuweWDS /> |
| − | ====Medicamenteuze behandeling | + | ====Medicamenteuze behandeling MBH_300_WDS_nieuweWDS ==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_WDS_nieuweWDS_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 6.476: | Regel 6.647: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_nieuweWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T - 20 dagen om 08:00 uur | |style="background-color: white;"|T - 20 dagen om 08:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.512: | Regel 6.683: | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|AanvullendeInstructie |
|style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_nieuweWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | WisselendDoseerschema MBH_300_WDS_nieuweWDS_WDS1 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 6.526: | Regel 6.697: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_nieuweWDS_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
|style="background-color: white;"|T - 20 dagen om 08:00 uur | |style="background-color: white;"|T - 20 dagen om 08:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.577: | Regel 6.748: | ||
|style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 4 stuks | |style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 4 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_nieuweWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_nieuweWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | WisselendDoseerschema MBH_300_WDS_nieuweWDS_WDS2 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 6.595: | Regel 6.766: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_nieuweWDS_WDS2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 5 dagen om 08:00 uur, tot en met T + 9 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 5 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 9 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
| Regel 6.629: | Regel 6.797: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="9"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"|eerst gedurende | + | |style="background-color: white;"|eerst gedurende 4 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, dan gedurende 4 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, dan gedurende 3 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 6.638: | Regel 6.806: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie 1 | |colspan="3"|Doseerinstructie 1 | ||
| − | |style="background-color: white;"|eerst gedurende | + | |style="background-color: white;"|eerst gedurende 4 dagen 1 maal per dag 3 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie 2 | |colspan="3"|Doseerinstructie 2 | ||
| Regel 6.644: | Regel 6.812: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie 3 | |colspan="3"|Doseerinstructie 3 | ||
| − | |style="background-color: white;"|dan gedurende | + | |style="background-color: white;"|dan gedurende 4 dagen 1 maal per dag 3 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie 4 | |colspan="3"|Doseerinstructie 4 | ||
|style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 4 stuks | |style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 4 stuks | ||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Doseerinstructie 5 |
| + | |style="background-color: white;"|dan gedurende 3 dagen 1 maal per dag 3 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Doseerinstructie 6 |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 4 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_nieuweWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_nieuweWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_WDS_nieuweWDS_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 6.674: | Regel 6.841: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_nieuweWDS_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen om 08:00 uur'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen om 08:00 uur |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Geneesmiddel - primaire code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|Geneesmiddel - | + | |colspan="4"|Geneesmiddel - generiekere code |
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 6.708: | Regel 6.872: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Volgens schema trombosedienst, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|AanvullendeInstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_nieuweWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_nieuweWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |} | + | |}<section end=MBH_MBH_300_WDS_nieuweWDS /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="MARCHA_VAN_PARTNERS" title="Intern ID = MARCHA_VAN_PARTNERS">Zorgverlener MARCHA_VAN_PARTNERS</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |rowspan="7"| |
| − | |style="background-color: white;"| | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| + | |colspan="3"|ZorgverlenerIdentificatienummer | ||
| + | |style="background-color: white;"|000001115 (in identificerend systeem: UZI Personen) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgegevens | ||
| + | |style="background-color: white;"|Marcha van Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Specialisme |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Zorgaanbieder |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Zorgaanbieder |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_ITIS|Zorgaanbieder: HUISARTSENPRAKTIJK_ITIS]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|<span id="TANJA_DE_BAKKER" title="Intern ID = TANJA_DE_BAKKER">Zorgverlener TANJA_DE_BAKKER</span> |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|ZorgverlenerIdentificatienummer |
| + | |style="background-color: white;"|222221111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Naamgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Tanja de Bakker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Specialisme |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgaanbieder | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="2"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Zorgaanbieder |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#TROMBOSEDIENST_ONS_DORP|Zorgaanbieder: TROMBOSEDIENST_ONS_DORP]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Adresgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_ITIS" title="Intern ID = HUISARTSENPRAKTIJK_ITIS">Zorgaanbieder HUISARTSENPRAKTIJK_ITIS</span> |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|00005111 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Huisartsenpraktijk Itis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |colspan="3"|Adresgegevens |
| + | |style="background-color: white;"|Werkadres: Langelaan 1 1234ZZ Onze Stad | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="TROMBOSEDIENST_ONS_DORP" title="Intern ID = TROMBOSEDIENST_ONS_DORP">Zorgaanbieder TROMBOSEDIENST_ONS_DORP</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="5"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|11112222 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Trombosedienst Ons Dorp | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|AfdelingSpecialisme |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Adresgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Kerkstraat 28 d 1332GH Ons Dorp |
| − | |}<section end= | + | |}<section end=ALLMBHS_XXX_Hulsing /> |
| + | ==Patiënt I XXX_Ruha== | ||
| + | <section begin=XXX_Ruha /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 6.818: | Regel 6.991: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Naamgegevens |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Initialen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|I |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Naamgebruik |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Geslachtsnaam |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="2"| | + | |colspan="2"|Achternaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Ruha |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="4"|Identificatienummer |
| + | |style="background-color: white;"|999909150 [BSN] | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geboortedatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|18 sep 1963 |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslacht | ||
| + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| + | |}<section end=XXX_Ruha /><section begin=ALLMBHS_XXX_Ruha /><section begin=MBH_MBH_300_WDS_wijzigWDS /> | ||
| + | ====Medicamenteuze behandeling MBH_300_WDS_wijzigWDS ==== | ||
| + | |||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_WDS_wijzigWDS_MA | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_wijzigWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 20 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Gebruiksperiode |
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen om 08:00 uur'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Ingangsdatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 20 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#MARCHA_VAN_PARTNERS|Zorgverlener: MARCHA_VAN_PARTNERS]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geneesmiddel - primaire code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Omschrijving |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Volgens schema trombosedienst, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Toedieningsweg |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|AanvullendeInstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="4"|MBH identificatie | |
| − | + | |style="background-color: white;"|MBH_300_WDS_wijzigWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
| − | |colspan=" | + | |} |
| − | |style="background-color: white;"| | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |} | ||
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | WisselendDoseerschema MBH_300_WDS_wijzigWDS_WDS1 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_wijzigWDS_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T - 20 dagen om 08:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Gebruiksperiode |
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen om 08:00 uur, tot en met T - 6 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 20 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Einddatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 6 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#TANJA_DE_BAKKER|Zorgverlener: TANJA_DE_BAKKER]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="7"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Omschrijving |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|eerst gedurende 6 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, dan gedurende 6 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Toedieningsweg |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
| − | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | = | + | |colspan="3"|Doseerinstructie 1 |
| − | + | |style="background-color: white;"|eerst gedurende 6 dagen 1 maal per dag 3 stuks | |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie 2 | ||
| + | |style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 4 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie 3 | ||
| + | |style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 3 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie 4 | ||
| + | |style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 4 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_wijzigWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_wijzigWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | WisselendDoseerschema MBH_300_WDS_wijzigWDS_WDS1_techstaken |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 6.945: | Regel 7.146: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_wijzigWDS_WDS1_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen om 08:00 uur, tot en met T - 10 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen om 08:00 uur |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Einddatum | ||
| + | |style="background-color: white;"|T - 10 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|WisselendDoseerschemaStopType | ||
| + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#TANJA_DE_BAKKER|Zorgverlener: TANJA_DE_BAKKER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| Regel 6.973: | Regel 7.180: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|eerst gedurende 6 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, dan gedurende 6 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Doseerinstructie 1 |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|eerst gedurende 6 dagen 1 maal per dag 3 stuks |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie 2 | ||
| + | |style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 4 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|MBH identificatie | + | |colspan="3"|Doseerinstructie 3 |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 3 stuks |
| − | |} | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| + | |colspan="3"|Doseerinstructie 4 | ||
| + | |style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 4 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_wijzigWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieWisselendDoseerschema | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_wijzigWDS_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_wijzigWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | WisselendDoseerschema MBH_300_WDS_wijzigWDS_WDS2 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 6.995: | Regel 7.225: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_wijzigWDS_WDS2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 9 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 9 dagen om 08:00 uur, tot en met T + 5 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 9 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 5 dagen |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#TANJA_DE_BAKKER|Zorgverlener: TANJA_DE_BAKKER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RedenWijzigenOfStaken |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| Regel 7.032: | Regel 7.259: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="9"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|eerst gedurende 4 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, dan gedurende 4 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, dan gedurende 3 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Doseerinstructie 1 |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|eerst gedurende 4 dagen 1 maal per dag 3 stuks |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Doseerinstructie 2 |
| + | |style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 4 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Doseerinstructie 3 |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|dan gedurende 4 dagen 1 maal per dag 3 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"|MBH identificatie | + | |colspan="3"|Doseerinstructie 4 |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 4 stuks |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie 5 | ||
| + | |style="background-color: white;"|dan gedurende 3 dagen 1 maal per dag 3 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie 6 | ||
| + | |style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 4 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_wijzigWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieWisselendDoseerschema | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_wijzigWDS_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_wijzigWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_WDS_wijzigWDS_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 7.061: | Regel 7.310: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_wijzigWDS_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 20 dagen om 08:00 uur'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 20 dagen om 08:00 uur |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.092: | Regel 7.341: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Volgens schema trombosedienst, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|AanvullendeInstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="2"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="3"|Identificatie | |
| − | + | |style="background-color: white;"|MBH_300_WDS_wijzigWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_wijzigWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |} | + | |}<section end=MBH_MBH_300_WDS_wijzigWDS /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="MARCHA_VAN_PARTNERS" title="Intern ID = MARCHA_VAN_PARTNERS">Zorgverlener MARCHA_VAN_PARTNERS</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgverlenerIdentificatienummer | ||
| + | |style="background-color: white;"|000001115 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Naamgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Marcha van Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Specialisme |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Zorgaanbieder |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Zorgaanbieder |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_ITIS|Zorgaanbieder: HUISARTSENPRAKTIJK_ITIS]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|<span id="TANJA_DE_BAKKER" title="Intern ID = TANJA_DE_BAKKER">Zorgverlener TANJA_DE_BAKKER</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|222221111 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Naamgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Tanja de Bakker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Specialisme |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Zorgaanbieder |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#TROMBOSEDIENST_ONS_DORP|Zorgaanbieder: TROMBOSEDIENST_ONS_DORP]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="4"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|OrganisatieNaam |
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Adresgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"|<span id=" | + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_ITIS" title="Intern ID = HUISARTSENPRAKTIJK_ITIS">Zorgaanbieder HUISARTSENPRAKTIJK_ITIS</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|00005111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsenpraktijk Itis |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Adresgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Langelaan 1 1234ZZ Onze Stad |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|<span id="TROMBOSEDIENST_ONS_DORP" title="Intern ID = TROMBOSEDIENST_ONS_DORP">Zorgaanbieder TROMBOSEDIENST_ONS_DORP</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="5"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|11112222 (in identificerend systeem: URA) |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|OrganisatieNaam |
| + | |style="background-color: white;"|Trombosedienst Ons Dorp | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|AfdelingSpecialisme |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="3"|Adresgegevens | |
| − | + | |style="background-color: white;"|Werkadres: Kerkstraat 28 d 1332GH Ons Dorp | |
| − | + | |}<section end=ALLMBHS_XXX_Ruha /> | |
| − | + | ==Patiënt K XXX_Walsmit== | |
| − | + | <section begin=XXX_Walsmit /> | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |colspan="3"|Adresgegevens | ||
| − | |style="background-color: white;"|Werkadres: Kerkstraat 28 d 1332GH Ons Dorp | ||
| − | |}<section end= | ||
| − | ==Patiënt | ||
| − | <section begin= | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 7.285: | Regel 7.465: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Initialen | |colspan="3"|Initialen | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|K |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgebruik | |colspan="3"|Naamgebruik | ||
| Regel 7.295: | Regel 7.475: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Walsmit |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999909162 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| Regel 7.304: | Regel 7.484: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end= | + | |}<section end=XXX_Walsmit /><section begin=ALLMBHS_XXX_Walsmit /><section begin=MBH_MBH_300_WDS_stopMA /> |
| − | ====Medicamenteuze behandeling | + | ====Medicamenteuze behandeling MBH_300_WDS_stopMA ==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_WDS_stopMA_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 7.316: | Regel 7.496: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_stopMA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 7 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 7 dagen om 08:00 uur'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 7 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| Regel 7.352: | Regel 7.532: | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|AanvullendeInstructie |
|style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_WDS_stopMA_stopMA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 7.366: | Regel 7.546: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_stopMA_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 7 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 7 dagen om 08:00 uur, tot en met T - 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 7 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 2 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MedicatieafspraakStopType | ||
| + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Zorgverlener | |colspan="3"|Zorgverlener | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#MARCHA_VAN_PARTNERS|Zorgverlener: MARCHA_VAN_PARTNERS]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RedenWijzigenOfStaken | ||
| + | |style="background-color: white;"|geneesmiddelinteractie (code = '79899007' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| Regel 7.397: | Regel 7.583: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Volgens schema trombosedienst, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|AanvullendeInstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_stopMA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | WisselendDoseerschema MBH_300_WDS_stopMA_WDS |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 7.435: | Regel 7.612: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_stopMA_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 7 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 7 dagen om 08:00 uur, tot en met T + 7 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 7 dagen om 08:00 uur |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Einddatum | ||
| + | |style="background-color: white;"|T + 7 dagen | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#TANJA_DE_BAKKER|Zorgverlener: TANJA_DE_BAKKER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| − | |||
| − | |||
| − | |||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.466: | Regel 7.643: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|eerst gedurende 6 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, dan gedurende 6 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Doseerinstructie 1 |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|eerst gedurende 6 dagen 1 maal per dag 3 stuks |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie 2 | ||
| + | |style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 4 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie 3 | ||
| + | |style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 3 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie 4 | ||
| + | |style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 4 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_stopMA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_WDS_stopMA_TA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 7.495: | Regel 7.681: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_stopMA_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 7 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 7 dagen om 08:00 uur'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 7 dagen om 08:00 uur |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Verstrekker | |colspan="5"|Verstrekker | ||
| Regel 7.540: | Regel 7.720: | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|AanvullendeInstructie |
|style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_stopMA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |} | + | |}<section end=MBH_MBH_300_WDS_stopMA /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="MARCHA_VAN_PARTNERS" title="Intern ID = MARCHA_VAN_PARTNERS">Zorgverlener MARCHA_VAN_PARTNERS</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="7"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|ZorgverlenerIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|000001115 (in identificerend systeem: UZI Personen) |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Naamgegevens |
| + | |style="background-color: white;"|Marcha van Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Specialisme |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="2"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_ITIS|Zorgaanbieder: HUISARTSENPRAKTIJK_ITIS]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="TANJA_DE_BAKKER" title="Intern ID = TANJA_DE_BAKKER">Zorgverlener TANJA_DE_BAKKER</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="7"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|ZorgverlenerIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|222221111 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Naamgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Tanja de Bakker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Specialisme |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Zorgaanbieder |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="2"|Zorgaanbieder |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#TROMBOSEDIENST_ONS_DORP|Zorgaanbieder: TROMBOSEDIENST_ONS_DORP]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Apotheek De Gulle Gaper |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Adresgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_ITIS" title="Intern ID = HUISARTSENPRAKTIJK_ITIS">Zorgaanbieder HUISARTSENPRAKTIJK_ITIS</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|00005111 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Huisartsenpraktijk Itis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Adresgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Langelaan 1 1234ZZ Onze Stad |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|<span id="TROMBOSEDIENST_ONS_DORP" title="Intern ID = TROMBOSEDIENST_ONS_DORP">Zorgaanbieder TROMBOSEDIENST_ONS_DORP</span> |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="5"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|11112222 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|OrganisatieNaam |
| + | |style="background-color: white;"|Trombosedienst Ons Dorp | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|AfdelingSpecialisme |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Adresgegevens |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Werkadres: Kerkstraat 28 d 1332GH Ons Dorp |
| − | |}<section end= | + | |}<section end=ALLMBHS_XXX_Walsmit /> |
| + | ==Patiënt J XXX_Poll== | ||
| + | <section begin=XXX_Poll /> | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 7.637: | Regel 7.831: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Naamgegevens |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="6"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Initialen |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|J |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Naamgebruik |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslachtsnaam | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="2"| |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="2"|Achternaam |
| + | |style="background-color: white;"|XXX_Poll | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Identificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999909174 [BSN] |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="4"|Geboortedatum |
| + | |style="background-color: white;"|18 sep 1963 | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geslacht |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| + | |}<section end=XXX_Poll /><section begin=ALLMBHS_XXX_Poll /><section begin=MBH_MBH_300_WDS_wijzigTA /> | ||
| + | ====Medicamenteuze behandeling MBH_300_WDS_wijzigTA ==== | ||
| + | |||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_WDS_wijzigTA_MA | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_wijzigTA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 10 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Gebruiksperiode |
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen om 08:00 uur'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Ingangsdatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 10 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Voorschrijver |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#MARCHA_VAN_PARTNERS|Zorgverlener: MARCHA_VAN_PARTNERS]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geneesmiddel - primaire code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Gebruiksinstructie |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Omschrijving |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Volgens schema trombosedienst, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Toedieningsweg |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|AanvullendeInstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst |
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="4"|MBH identificatie | |
| − | + | |style="background-color: white;"|MBH_300_WDS_wijzigTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |
| − | |colspan=" | + | |} |
| − | |style="background-color: white;"| | ||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |} | ||
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | WisselendDoseerschema MBH_300_WDS_wijzigTA_WDS |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_wijzigTA_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T - 10 dagen om 08:00 uur | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="4"|Gebruiksperiode |
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen om 08:00 uur, tot en met T + 4 dagen'' | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Ingangsdatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T - 10 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Einddatum |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|T + 4 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="5"|Auteur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Zie [[#TANJA_DE_BAKKER|Zorgverlener: TANJA_DE_BAKKER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Geneesmiddel - primaire code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Gebruiksinstructie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Omschrijving | ||
| + | |style="background-color: white;"|eerst gedurende 6 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, dan gedurende 6 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, Oraal | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Toedieningsweg | ||
| + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie 1 | ||
| + | |style="background-color: white;"|eerst gedurende 6 dagen 1 maal per dag 3 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie 2 | ||
| + | |style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 4 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie 3 | ||
| + | |style="background-color: white;"|dan gedurende 6 dagen 1 maal per dag 3 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie 4 | ||
| + | |style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 4 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_wijzigTA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|MBH identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_wijzigTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |} | + | |} |
| − | |||
| − | |||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_WDS_wijzigTA_TA1 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 7.764: | Regel 7.986: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_wijzigTA_TA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen om 08:00 uur'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.800: | Regel 8.025: | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|AanvullendeInstructie |
|style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_wijzigTA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_wijzigTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_WDS_wijzigTA_stopTA1 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 7.814: | Regel 8.046: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_wijzigTA_stopTA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 10 dagen om 08:00 uur, tot en met T - 5 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 10 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 5 dagen |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ToedieningsafspraakStopType | ||
| + | |style="background-color: white;"|stopgezet (code = '410546004' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.845: | Regel 8.083: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Volgens schema trombosedienst, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|AanvullendeInstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="2"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_wijzigTA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_wijzigTA_stopTA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_wijzigTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_WDS_wijzigTA_TA2 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 7.883: | Regel 8.119: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_wijzigTA_TA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 4 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen om 08:00 uur'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="2"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T - 4 dagen om 08:00 uur |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|Verstrekker |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Zorgaanbieder |
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ToedieningsafspraakRedenWijzigenOfStaken | ||
| + | |style="background-color: white;"|geneesmiddel niet voorradig (code = '182856006' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geneesmiddel - primaire code | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|ACENOCOUMAROL AURO TABLET 1MG (code = '1101196' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
|style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 7.914: | Regel 8.153: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Volgens schema trombosedienst, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|AanvullendeInstructie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_wijzigTA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieToedieningsafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_wijzigTA_TA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_wijzigTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
| − | |} | + | |}<section end=MBH_MBH_300_WDS_wijzigTA /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="MARCHA_VAN_PARTNERS" title="Intern ID = MARCHA_VAN_PARTNERS">Zorgverlener MARCHA_VAN_PARTNERS</span> | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |rowspan="7"| |
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan=" | + | |colspan="3"|ZorgverlenerIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|000001115 (in identificerend systeem: UZI Personen) |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | | | + | |colspan="3"|Naamgegevens |
| + | |style="background-color: white;"|Marcha van Partners | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|Specialisme |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | + | |colspan="4"|Zorgaanbieder | |
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |||
| − | |colspan="4"|Zorgaanbieder | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
| Regel 8.036: | Regel 8.212: | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
|style="background-color: white;"|222221111 (in identificerend systeem: UZI Personen) | |style="background-color: white;"|222221111 (in identificerend systeem: UZI Personen) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.056: | Regel 8.232: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.069: | Regel 8.245: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|00005111 (in identificerend systeem: URA) | |style="background-color: white;"|00005111 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Huisartsenpraktijk Itis | |style="background-color: white;"|Huisartsenpraktijk Itis | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.082: | Regel 8.258: | ||
|rowspan="5"| | |rowspan="5"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|11112222 (in identificerend systeem: URA) | |style="background-color: white;"|11112222 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Trombosedienst Ons Dorp | |style="background-color: white;"|Trombosedienst Ons Dorp | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|AfdelingSpecialisme |
|style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Adresgegevens | |colspan="3"|Adresgegevens | ||
|style="background-color: white;"|Werkadres: Kerkstraat 28 d 1332GH Ons Dorp | |style="background-color: white;"|Werkadres: Kerkstraat 28 d 1332GH Ons Dorp | ||
| − | |}<section end= | + | |}<section end=ALLMBHS_XXX_Poll /> |
| − | ==Patiënt J | + | ==Patiënt J XXX_Eijken== |
| − | <section begin= | + | <section begin=XXX_Eijken /> |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
|style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| Regel 8.118: | Regel 8.294: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Achternaam | |colspan="2"|Achternaam | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|XXX_Eijken |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatienummer | |colspan="4"|Identificatienummer | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|999909186 [BSN] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geboortedatum | |colspan="4"|Geboortedatum | ||
| Regel 8.127: | Regel 8.303: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Geslacht | |colspan="4"|Geslacht | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') |
| − | |}<section end= | + | |}<section end=XXX_Eijken /><section begin=ALLMBHS_XXX_Eijken /><section begin=MBH_MBH_300_WDS_toekomstWDS /> |
| − | ====Medicamenteuze behandeling | + | ====Medicamenteuze behandeling MBH_300_WDS_toekomstWDS ==== |
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_WDS_toekomstWDS_MA |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 8.139: | Regel 8.315: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_toekomstWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 6 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 6 dagen om 08:00 uur'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 6 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Voorschrijver | |colspan="5"|Voorschrijver | ||
| Regel 8.175: | Regel 8.351: | ||
|style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|AanvullendeInstructie |
|style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_toekomstWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | WisselendDoseerschema MBH_300_WDS_toekomstWDS_WDS1 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 8.189: | Regel 8.365: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_toekomstWDS_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 6 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T - | + | |style="background-color: #E3E3E3;;"|''Vanaf T - 6 dagen om 08:00 uur, tot en met T + 2 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="3"| | |rowspan="3"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 6 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Einddatum | |colspan="3"|Einddatum | ||
| − | |style="background-color: white;"|T + | + | |style="background-color: white;"|T + 2 dagen |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|Auteur | |colspan="5"|Auteur | ||
| Regel 8.220: | Regel 8.396: | ||
|colspan="5"|Gebruiksinstructie | |colspan="5"|Gebruiksinstructie | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="7"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Omschrijving | |colspan="3"|Omschrijving | ||
| − | |style="background-color: white;"|eerst gedurende | + | |style="background-color: white;"|eerst gedurende 3 dagen 1 maal per dag 2 stuks, dan gedurende 1 dag 1 maal per dag 3 stuks, dan gedurende 2 dagen 1 maal per dag 2 stuks, dan gedurende 1 dag 1 maal per dag 3 stuks, Oraal |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Toedieningsweg | |colspan="3"|Toedieningsweg | ||
| Regel 8.229: | Regel 8.405: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie 1 | |colspan="3"|Doseerinstructie 1 | ||
| − | |style="background-color: white;"|eerst gedurende | + | |style="background-color: white;"|eerst gedurende 3 dagen 1 maal per dag 2 stuks |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Doseerinstructie 2 | |colspan="3"|Doseerinstructie 2 | ||
| Regel 8.236: | Regel 8.412: | ||
|colspan="3"|Doseerinstructie 3 | |colspan="3"|Doseerinstructie 3 | ||
|style="background-color: white;"|dan gedurende 2 dagen 1 maal per dag 2 stuks | |style="background-color: white;"|dan gedurende 2 dagen 1 maal per dag 2 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie 4 | ||
| + | |style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 3 stuks | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"| | + | |colspan="5"|RelatieMedicatieafspraak |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="2"| | |rowspan="2"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Identificatie | |colspan="3"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_toekomstWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|MBH identificatie | |colspan="4"|MBH identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_toekomstWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) |
|} | |} | ||
{| class="wikitable" width="85%" | {| class="wikitable" width="85%" | ||
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | | + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | WisselendDoseerschema MBH_300_WDS_toekomstWDS_WDS2 |
|-style="background-color: #1F497D;; color: white; text-align:left;" | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
| Regel 8.255: | Regel 8.434: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Identificatie | |colspan="4"|Identificatie | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_toekomstWDS_WDS2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="4"| | + | |colspan="4"|RegistratieDatumTijd |
| − | |style="background-color: white;"|T - | + | |style="background-color: white;"|T - 3 dagen om 08:00 uur |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Gebruiksperiode | |colspan="4"|Gebruiksperiode | ||
| − | |style="background-color: #E3E3E3;;"|''Vanaf T | + | |style="background-color: #E3E3E3;;"|''Vanaf T + 2 dagen om 08:00 uur, tot en met T + 16 dagen'' |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="3"| |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Ingangsdatum | |colspan="3"|Ingangsdatum | ||
| − | |style="background-color: white;"|T | + | |style="background-color: white;"|T + 2 dagen om 08:00 uur |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |colspan="5"| | + | |colspan="3"|Einddatum |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |style="background-color: white;"|T + 16 dagen |
| − | |rowspan="2"| | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |colspan="5"|Auteur |
| − | |colspan="3"| | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |style="background-color: white;"|Zie [[# | + | |rowspan="2"| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |colspan="4"|Geneesmiddel - primaire code | + | |colspan="3"|Zorgverlener |
| − | |style="background-color: white;"|ACENOCOUMAROL | + | |style="background-color: white;"|Zie [[#TANJA_DE_BAKKER|Zorgverlener: TANJA_DE_BAKKER]] |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |colspan="4"|Geneesmiddel - generiekere code | + | |colspan="4"|Geneesmiddel - primaire code |
| − | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = ' | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |colspan=" | + | |colspan="4"|Geneesmiddel - generiekere code |
| − | + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | | | + | |colspan="5"|Gebruiksinstructie |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | | | + | |rowspan="5"| |
| − | | | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | | | + | |colspan="3"|Omschrijving |
| − | + | |style="background-color: white;"|eerst gedurende 6 dagen 1 maal per dag 2 stuks, dan gedurende 1 dag 1 maal per dag 3 stuks, Oraal | |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |colspan="3"|Toedieningsweg | + | |colspan="3"|Toedieningsweg |
| − | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |colspan="3"| | + | |colspan="3"|Doseerinstructie 1 |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|eerst gedurende 6 dagen 1 maal per dag 2 stuks |
| − | + | |-style="vertical-align:top; background-color: #E3E3E3;;" | |
| − | + | |colspan="3"|Doseerinstructie 2 | |
| − | + | |style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 3 stuks | |
| − | |rowspan="2"| | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |colspan="5"|RelatieMedicatieafspraak |
| − | |colspan=" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |style="background-color: white;"| | + | |rowspan="2"| |
| − | |-style="vertical-align:top; background-color: #E3E3E3;;" | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |colspan=" | + | |colspan="3"|Identificatie |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|MBH_300_WDS_toekomstWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) |
| − | |}<section end= | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | {| class="wikitable" width="85%" | + | |colspan="5"|RelatieWisselendDoseerschema |
| − | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | + | |-style="vertical-align:top; background-color: #E3E3E3;;" |
| − | |-style="background-color: #1F497D;; color: white; text-align:left;" | + | |rowspan="2"| |
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_toekomstWDS_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_toekomstWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_WDS_toekomstWDS_TA | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_toekomstWDS_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T - 6 dagen om 08:00 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksperiode | ||
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 6 dagen om 08:00 uur'' | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Ingangsdatum | ||
| + | |style="background-color: white;"|T - 6 dagen om 08:00 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Gebruiksinstructie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Omschrijving | ||
| + | |style="background-color: white;"|Volgens schema trombosedienst, Oraal | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Toedieningsweg | ||
| + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|AanvullendeInstructie | ||
| + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_toekomstWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_toekomstWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |}<section end=MBH_MBH_300_WDS_toekomstWDS /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="MARCHA_VAN_PARTNERS" title="Intern ID = MARCHA_VAN_PARTNERS">Zorgverlener MARCHA_VAN_PARTNERS</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgverlenerIdentificatienummer | ||
| + | |style="background-color: white;"|000001115 (in identificerend systeem: UZI Personen) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgegevens | ||
| + | |style="background-color: white;"|Marcha van Partners | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Specialisme | ||
| + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_ITIS|Zorgaanbieder: HUISARTSENPRAKTIJK_ITIS]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="TANJA_DE_BAKKER" title="Intern ID = TANJA_DE_BAKKER">Zorgverlener TANJA_DE_BAKKER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgverlenerIdentificatienummer | ||
| + | |style="background-color: white;"|222221111 (in identificerend systeem: UZI Personen) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgegevens | ||
| + | |style="background-color: white;"|Tanja de Bakker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Specialisme | ||
| + | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#TROMBOSEDIENST_ONS_DORP|Zorgaanbieder: TROMBOSEDIENST_ONS_DORP]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_ITIS" title="Intern ID = HUISARTSENPRAKTIJK_ITIS">Zorgaanbieder HUISARTSENPRAKTIJK_ITIS</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|00005111 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Huisartsenpraktijk Itis | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Langelaan 1 1234ZZ Onze Stad | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="TROMBOSEDIENST_ONS_DORP" title="Intern ID = TROMBOSEDIENST_ONS_DORP">Zorgaanbieder TROMBOSEDIENST_ONS_DORP</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="5"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|11112222 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Trombosedienst Ons Dorp | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|AfdelingSpecialisme | ||
| + | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Kerkstraat 28 d 1332GH Ons Dorp | ||
| + | |}<section end=ALLMBHS_XXX_Eijken /> | ||
| + | ==Patiënt J XXX_Verstelle== | ||
| + | <section begin=XXX_Verstelle /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Naamgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="6"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Initialen | ||
| + | |style="background-color: white;"|J | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgebruik | ||
| + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslachtsnaam | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Achternaam | ||
| + | |style="background-color: white;"|XXX_Verstelle | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatienummer | ||
| + | |style="background-color: white;"|999909198 [BSN] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geboortedatum | ||
| + | |style="background-color: white;"|18 sep 1963 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslacht | ||
| + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| + | |}<section end=XXX_Verstelle /><section begin=ALLMBHS_XXX_Verstelle /><section begin=MBH_MBH_300_WDS_OnderbrokenMA /> | ||
| + | ====Medicamenteuze behandeling MBH_300_WDS_OnderbrokenMA ==== | ||
| + | |||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_WDS_OnderbrokenMA_MA | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_OnderbrokenMA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T - 4 dagen om 08:00 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksperiode | ||
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen om 08:00 uur'' | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Ingangsdatum | ||
| + | |style="background-color: white;"|T - 4 dagen om 08:00 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Voorschrijver | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#MARCHA_VAN_PARTNERS|Zorgverlener: MARCHA_VAN_PARTNERS]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Gebruiksinstructie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Omschrijving | ||
| + | |style="background-color: white;"|Volgens schema trombosedienst, Oraal | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Toedieningsweg | ||
| + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|AanvullendeInstructie | ||
| + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_OnderbrokenMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | WisselendDoseerschema MBH_300_WDS_OnderbrokenMA_WDS | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_OnderbrokenMA_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T - 4 dagen om 08:00 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksperiode | ||
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen om 08:00 uur, tot en met T + 3 dagen'' | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Ingangsdatum | ||
| + | |style="background-color: white;"|T - 4 dagen om 08:00 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Einddatum | ||
| + | |style="background-color: white;"|T + 3 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Auteur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#TANJA_DE_BAKKER|Zorgverlener: TANJA_DE_BAKKER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Gebruiksinstructie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="6"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Omschrijving | ||
| + | |style="background-color: white;"|eerst gedurende 4 dagen 1 maal per dag 2 stuks, dan gedurende 1 dag 1 maal per dag 3 stuks, dan gedurende 2 dagen 1 maal per dag 2 stuks, Oraal | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Toedieningsweg | ||
| + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie 1 | ||
| + | |style="background-color: white;"|eerst gedurende 4 dagen 1 maal per dag 2 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie 2 | ||
| + | |style="background-color: white;"|dan gedurende 1 dag 1 maal per dag 3 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie 3 | ||
| + | |style="background-color: white;"|dan gedurende 2 dagen 1 maal per dag 2 stuks | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_OnderbrokenMA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_OnderbrokenMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_WDS_OnderbrokenMA_TA | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_OnderbrokenMA_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T - 4 dagen om 08:00 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksperiode | ||
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 4 dagen om 08:00 uur'' | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Ingangsdatum | ||
| + | |style="background-color: white;"|T - 4 dagen om 08:00 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Gebruiksinstructie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Omschrijving | ||
| + | |style="background-color: white;"|Volgens schema trombosedienst, Oraal | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Toedieningsweg | ||
| + | |style="background-color: white;"|Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|AanvullendeInstructie | ||
| + | |style="background-color: white;"|overig (code = 'OTH' in codeSystem '<span title="2.16.840.1.113883.5.1008">HL7 NullFlavor</span>'): Volgens schema trombosedienst | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_OnderbrokenMA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_WDS_OnderbrokenMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |}<section end=MBH_MBH_300_WDS_OnderbrokenMA /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="MARCHA_VAN_PARTNERS" title="Intern ID = MARCHA_VAN_PARTNERS">Zorgverlener MARCHA_VAN_PARTNERS</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgverlenerIdentificatienummer | ||
| + | |style="background-color: white;"|000001115 (in identificerend systeem: UZI Personen) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgegevens | ||
| + | |style="background-color: white;"|Marcha van Partners | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Specialisme | ||
| + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_ITIS|Zorgaanbieder: HUISARTSENPRAKTIJK_ITIS]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="TANJA_DE_BAKKER" title="Intern ID = TANJA_DE_BAKKER">Zorgverlener TANJA_DE_BAKKER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgverlenerIdentificatienummer | ||
| + | |style="background-color: white;"|222221111 (in identificerend systeem: UZI Personen) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgegevens | ||
| + | |style="background-color: white;"|Tanja de Bakker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Specialisme | ||
| + | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#TROMBOSEDIENST_ONS_DORP|Zorgaanbieder: TROMBOSEDIENST_ONS_DORP]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_ITIS" title="Intern ID = HUISARTSENPRAKTIJK_ITIS">Zorgaanbieder HUISARTSENPRAKTIJK_ITIS</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|00005111 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Huisartsenpraktijk Itis | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Langelaan 1 1234ZZ Onze Stad | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="TROMBOSEDIENST_ONS_DORP" title="Intern ID = TROMBOSEDIENST_ONS_DORP">Zorgaanbieder TROMBOSEDIENST_ONS_DORP</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="5"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|11112222 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Trombosedienst Ons Dorp | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|AfdelingSpecialisme | ||
| + | |style="background-color: white;"|Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Kerkstraat 28 d 1332GH Ons Dorp | ||
| + | |}<section end=ALLMBHS_XXX_Verstelle /> | ||
| + | ==Patiënt A XXX_Maasbommel== | ||
| + | <section begin=XXX_Maasbommel /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Naamgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="6"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Voornamen | ||
| + | |style="background-color: white;"|A | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgebruik | ||
| + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslachtsnaam | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Achternaam | ||
| + | |style="background-color: white;"|XXX_Maasbommel | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatienummer | ||
| + | |style="background-color: white;"|999908856 [BSN] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geboortedatum | ||
| + | |style="background-color: white;"|25 feb 1912 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslacht | ||
| + | |style="background-color: white;"|Man (code = 'M' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| + | |}<section end=XXX_Maasbommel /><section begin=ALLMBHS_XXX_Maasbommel /><section begin=MBH_MBH_300_spoedtoediening /> | ||
| + | ====Medicamenteuze behandeling MBH_300_spoedtoediening ==== | ||
| + | |||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatietoediening MBH_300_spoedtoediening_MTD | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_spoedtoediening_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T - 4 dagen om 08:00 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|ToedieningsDatumTijd | ||
| + | |style="background-color: white;"|T - 4 dagen om 08:00 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|ToegediendeHoeveelheid | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Aantal | ||
| + | |style="background-color: white;"|2 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Eenheid | ||
| + | |style="background-color: white;"|dosis (code = '208' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Toedieningsweg | ||
| + | |style="background-color: white;"|sublinguaal (code = '121' in codeSystem 'G-Standaard Toedieningswegen') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Toediener | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#PETER_VAN_PULVER|Zorgverlener: PETER_VAN_PULVER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|NITROLINGUAL OROMUCOSALE SPRAY 0,4MG/DO FLAC 250DO (code = '704369' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|NITROGLYCERINE SPRAY SUBLING. 0,4MG/DO FL 250DO (code = '72214' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|NITROGLYCERINE SPRAY SUBLING. 0,4MG/DO (code = '119431' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_spoedtoediening (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |}<section end=MBH_MBH_300_spoedtoediening /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="PETER_VAN_PULVER" title="Intern ID = PETER_VAN_PULVER">Zorgverlener PETER_VAN_PULVER</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgverlenerIdentificatienummer | ||
| + | |style="background-color: white;"|000001111 (in identificerend systeem: UZI Personen) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgegevens | ||
| + | |style="background-color: white;"|Peter van Pulver | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Specialisme | ||
| + | |style="background-color: white;"|Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgaanbieder | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|ZorgaanbiederIdentificatienummer | ||
| + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|OrganisatieNaam | ||
| + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Adresgegevens | ||
| + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp | ||
| + | |}<section end=ALLMBHS_XXX_Maasbommel /> | ||
| + | ==Patiënt A van de XXX_Toorn== | ||
| + | <section begin=XXX_Toorn /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Patiënt | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Naamgegevens | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="7"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Voornamen | ||
| + | |style="background-color: white;"|A | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Naamgebruik | ||
| + | |style="background-color: white;"|Eigen geslachtsnaam (code = 'NL1' in codeSystem '<span title="2.16.840.1.113883.2.4.3.11.60.101.5.4">ZIB Naamgebruik</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslachtsnaam | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Voorvoegsels | ||
| + | |style="background-color: white;"|van de | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="2"|Achternaam | ||
| + | |style="background-color: white;"|XXX_Toorn | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatienummer | ||
| + | |style="background-color: white;"|999908868 [BSN] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geboortedatum | ||
| + | |style="background-color: white;"|18 sep 1963 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geslacht | ||
| + | |style="background-color: white;"|Vrouw (code = 'F' in codeSystem '<span title="2.16.840.1.113883.5.1">HL7 AdministrativeGender</span>') | ||
| + | |}<section end=XXX_Toorn /><section begin=ALLMBHS_XXX_Toorn /><section begin=MBH_MBH_300_prikplak /> | ||
| + | ====Medicamenteuze behandeling MBH_300_prikplak ==== | ||
| + | |||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Medicatieafspraak MBH_300_prikplak_MA | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_prikplak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T - 51 dagen om 08:05 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksperiode | ||
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen'' | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Ingangsdatum | ||
| + | |style="background-color: white;"|T - 50 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Voorschrijver | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#BERTINE_VAN_DOORN|Zorgverlener: BERTINE_VAN_DOORN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|INSULINE ASPART INJVLST 100E/ML PATR 3ML (code = '53902' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|INSULINE ASPART INJVLST 100E/ML (code = '108251' in codeSystem 'G-Standaard GPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Gebruiksinstructie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Omschrijving | ||
| + | |style="background-color: white;"|1 maal per dag 1 dosis, subcutaan | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Toedieningsweg | ||
| + | |style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie | ||
| + | |style="background-color: white;"|1 maal per dag 1 dosis | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_prikplak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Toedieningsafspraak MBH_300_prikplak_TA | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="4" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_prikplak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T - 51 dagen om 08:05 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Gebruiksperiode | ||
| + | |style="background-color: #E3E3E3;;"|''Vanaf T - 50 dagen'' | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Ingangsdatum | ||
| + | |style="background-color: white;"|T - 50 dagen | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Verstrekker | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Zorgaanbieder | ||
| + | |style="background-color: white;"|Zie [[#APOTHEEK_DE_GULLE_GAPER|Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|NOVORAPID PENFILL INJVLST 100E/ML PATROON 3ML (code = '1185063' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|INSULINE ASPART INJVLST 100E/ML PATR 3ML (code = '53902' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Gebruiksinstructie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="4"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Omschrijving | ||
| + | |style="background-color: white;"|1 maal per dag 1 dosis, subcutaan | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Toedieningsweg | ||
| + | |style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Doseerinstructie | ||
| + | |style="background-color: white;"|1 maal per dag 1 dosis | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_prikplak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_prikplak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatietoediening MBH_300_prikplak_MTD1 | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="5" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_prikplak_MTD1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T - 3 dagen om 08:10 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|ToedieningsDatumTijd | ||
| + | |style="background-color: white;"|T - 3 dagen om 08:10 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|ToegediendeHoeveelheid | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Aantal | ||
| + | |style="background-color: white;"|1 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Eenheid | ||
| + | |style="background-color: white;"|dosis (code = '208' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Toedieningsweg | ||
| + | |style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|PrikPlakLocatie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="5"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|AnatomischeLocatie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Locatie | ||
| + | |style="background-color: white;"|structuur van huid van anterieur oppervlak van bovenarm (code = '45981001' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Lateraliteit | ||
| + | |style="background-color: white;"|links (code = '7771000' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|Toediener | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|NOVORAPID PENFILL INJVLST 100E/ML PATROON 3ML (code = '1185063' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|INSULINE ASPART INJVLST 100E/ML PATR 3ML (code = '53902' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_prikplak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|RelatieToedieningsafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_prikplak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_prikplak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatietoediening MBH_300_prikplak_MTD2 | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="5" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_prikplak_MTD2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T - 2 dagen om 08:15 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|ToedieningsDatumTijd | ||
| + | |style="background-color: white;"|T - 2 dagen om 08:15 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|ToegediendeHoeveelheid | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Aantal | ||
| + | |style="background-color: white;"|1 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Eenheid | ||
| + | |style="background-color: white;"|dosis (code = '208' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Toedieningsweg | ||
| + | |style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|PrikPlakLocatie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="5"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|AnatomischeLocatie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Locatie | ||
| + | |style="background-color: white;"|structuur van huid van anterieur oppervlak van bovenarm (code = '45981001' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Lateraliteit | ||
| + | |style="background-color: white;"|rechts (code = '24028007' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|Toediener | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|NOVORAPID PENFILL INJVLST 100E/ML PATROON 3ML (code = '1185063' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|INSULINE ASPART INJVLST 100E/ML PATR 3ML (code = '53902' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_prikplak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|RelatieToedieningsafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_prikplak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_prikplak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatietoediening MBH_300_prikplak_MTD3 | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="5" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_prikplak_MTD3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T - 1 dag om 08:09 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|ToedieningsDatumTijd | ||
| + | |style="background-color: white;"|T - 1 dag om 08:09 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|ToegediendeHoeveelheid | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Aantal | ||
| + | |style="background-color: white;"|1 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Eenheid | ||
| + | |style="background-color: white;"|dosis (code = '208' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Toedieningsweg | ||
| + | |style="background-color: white;"|subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|PrikPlakLocatie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="5"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|AnatomischeLocatie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Locatie | ||
| + | |style="background-color: white;"|structuur van weke delen van laterale bovenkwadrant van anterieur oppervlak van bovenbeen (code = '160521000146106' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Lateraliteit | ||
| + | |style="background-color: white;"|links (code = '7771000' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|Toediener | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|NOVORAPID PENFILL INJVLST 100E/ML PATROON 3ML (code = '1185063' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|INSULINE ASPART INJVLST 100E/ML PATR 3ML (code = '53902' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_prikplak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|RelatieToedieningsafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_prikplak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_prikplak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |} | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="6" | Medicatietoediening MBH_300_prikplak_MTD4 | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
| + | |colspan="5" width="25%"| Gegevenselement | ||
| + | || Waarde | ||
| + | |||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_prikplak_MTD4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|RegistratieDatumTijd | ||
| + | |style="background-color: white;"|T om 08:04 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|ToedieningsDatumTijd | ||
| + | |style="background-color: white;"|T om 08:04 uur | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|ToegediendeHoeveelheid | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Aantal | ||
| + | |style="background-color: white;"|1 | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Eenheid | ||
| + | |style="background-color: white;"|dosis (code = '208' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Toedieningsweg | ||
| + | |style="background-color: white;"|stuk (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|PrikPlakLocatie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="5"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|AnatomischeLocatie | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="3"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Locatie | ||
| + | |style="background-color: white;"|structuur van weke delen van laterale bovenkwadrant van anterieur oppervlak van bovenbeen (code = '160521000146106' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="3"|Lateraliteit | ||
| + | |style="background-color: white;"|rechts (code = '24028007' in codeSystem '<span title="2.16.840.1.113883.6.96">SNOMED CT</span>') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|Toediener | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Zorgverlener | ||
| + | |style="background-color: white;"|Zie [[#JANTIEN_TOEDIEN|Zorgverlener: JANTIEN_TOEDIEN]] | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Geneesmiddel - primaire code | ||
| + | |style="background-color: white;"|NOVORAPID PENFILL INJVLST 100E/ML PATROON 3ML (code = '1185063' in codeSystem 'G-Standaard HPK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|Geneesmiddel - generiekere code | ||
| + | |style="background-color: white;"|INSULINE ASPART INJVLST 100E/ML PATR 3ML (code = '53902' in codeSystem 'G-Standaard PRK') | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|RelatieMedicatieafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_prikplak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="6"|RelatieToedieningsafspraak | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |rowspan="2"| | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="4"|Identificatie | ||
| + | |style="background-color: white;"|MBH_300_prikplak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||
| + | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| + | |colspan="5"|MBH identificatie | ||
| + | |style="background-color: white;"|MBH_300_prikplak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||
| + | |}<section end=MBH_MBH_300_prikplak /> | ||
| + | {| class="wikitable" width="85%" | ||
| + | |style="background-color: #1F497D;; color: white; font-weight: bold; text-align:center;" colspan="5" | Bouwstenen | ||
| + | |-style="background-color: #1F497D;; color: white; text-align:left;" | ||
|colspan="4" width="25%"| Gegevenselement | |colspan="4" width="25%"| Gegevenselement | ||
|| Waarde | || Waarde | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"|<span id=" | + | |colspan="5"|<span id="BERTINE_VAN_DOORN" title="Intern ID = BERTINE_VAN_DOORN">Zorgverlener BERTINE_VAN_DOORN</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|000001112 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgegevens | |colspan="3"|Naamgegevens | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Bertine van Doorn |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Specialisme | |colspan="3"|Specialisme | ||
| Regel 8.332: | Regel 9.536: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS|Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"|<span id=" | + | |colspan="5"|<span id="JANTIEN_TOEDIEN" title="Intern ID = JANTIEN_TOEDIEN">Zorgverlener JANTIEN_TOEDIEN</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="7"| | |rowspan="7"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgverlenerIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|222220000 (in identificerend systeem: UZI Personen) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Naamgegevens | |colspan="3"|Naamgegevens | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Jantien Toedien |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Specialisme | |colspan="3"|Specialisme | ||
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="4"|Zorgaanbieder | |colspan="4"|Zorgaanbieder | ||
| Regel 8.352: | Regel 9.556: | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="2"|Zorgaanbieder | |colspan="2"|Zorgaanbieder | ||
| − | |style="background-color: white;"|Zie [[# | + | |style="background-color: white;"|Zie [[#THUISZORG_OM_EN_BIJ|Zorgaanbieder: THUISZORG_OM_EN_BIJ]] |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="5"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | |colspan="5"|<span id="APOTHEEK_DE_GULLE_GAPER" title="Intern ID = APOTHEEK_DE_GULLE_GAPER">Zorgaanbieder APOTHEEK_DE_GULLE_GAPER</span> | ||
| Regel 8.358: | Regel 9.562: | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
|style="background-color: white;"|01236578 (in identificerend systeem: URA) | |style="background-color: white;"|01236578 (in identificerend systeem: URA) | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
|style="background-color: white;"|Apotheek De Gulle Gaper | |style="background-color: white;"|Apotheek De Gulle Gaper | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| Regel 8.367: | Regel 9.571: | ||
|style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |style="background-color: white;"|Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"|<span id=" | + | |colspan="5"|<span id="HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS" title="Intern ID = HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS">Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|rowspan="4"| | |rowspan="4"| | ||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|00001111 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
| − | |style="background-color: white;"|Huisartsenpraktijk | + | |style="background-color: white;"|Huisartsenpraktijk Pulver & Partners |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
|colspan="3"|Adresgegevens | |colspan="3"|Adresgegevens | ||
| − | |style="background-color: white;"|Werkadres: | + | |style="background-color: white;"|Werkadres: Dorpsstraat 1 1234AA Ons Dorp |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="5"|<span id=" | + | |colspan="5"|<span id="THUISZORG_OM_EN_BIJ" title="Intern ID = THUISZORG_OM_EN_BIJ">Zorgaanbieder THUISZORG_OM_EN_BIJ</span> |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |rowspan=" | + | |rowspan="4"| |
| − | |||
| − | |||
| − | |||
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|ZorgaanbiederIdentificatienummer |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|11110000 (in identificerend systeem: URA) |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieNaam |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Thuiszorg Om en Bij |
|-style="vertical-align:top; background-color: #E3E3E3;;" | |-style="vertical-align:top; background-color: #E3E3E3;;" | ||
| − | |colspan="3"| | + | |colspan="3"|OrganisatieType |
| − | |style="background-color: white;"| | + | |style="background-color: white;"|Thuiszorg (code = 'T2' in codeSystem '<span title="2.16.840.1.113883.2.4.15.1060">HL7 RoleCodeNL Care provider type (organizations)</span>') |
| − | |}<section end= | + | |}<section end=ALLMBHS_XXX_Toorn /> |
[[Categorie:Kwalificatie]] | [[Categorie:Kwalificatie]] | ||
Versie van 7 aug 2025 om 07:28
Inhoud
- 1 Addenda voor inhoudelijke gegevens
- 1.1 Patiënt J de XXX_Rover
- 1.1.1 Medicamenteuze behandeling MBH_300_gestopt
- 1.1.2 Medicamenteuze behandeling MBH_300_gewijzigd
- 1.1.3 Medicamenteuze behandeling MBH_300_gewijzigddoorander
- 1.1.4 Medicamenteuze behandeling MBH_300_onderbroken
- 1.1.5 Medicamenteuze behandeling MBH_300_andermans1
- 1.1.6 Medicamenteuze behandeling MBH_300_andermans2
- 1.1.7 Medicamenteuze behandeling MBH_300_geannuleerd
- 1.1.8 Medicamenteuze behandeling MBH_300_toekomstig
- 1.1.9 Medicamenteuze behandeling MBH_300_gestoptandermans
- 1.1.10 Medicamenteuze behandeling MBH_300_gewijzigd_toekomst
- 1.1.11 Medicamenteuze behandeling MBH_300_gebruik
- 1.2 Patiënt J XXX_Vriends
- 1.3 Patiënt J van de XXX_Lans
- 1.4 Patiënt J van XXX_Noort
- 1.5 Patiënt j XXX_Schoutens
- 1.6 Patiënt J de XXX_Groote
- 1.7 Patiënt H XXX_Snijdewint
- 1.8 Patiënt H XXX_Hulsing
- 1.9 Patiënt I XXX_Ruha
- 1.10 Patiënt K XXX_Walsmit
- 1.11 Patiënt J XXX_Poll
- 1.12 Patiënt J XXX_Eijken
- 1.13 Patiënt J XXX_Verstelle
- 1.14 Patiënt A XXX_Maasbommel
- 1.15 Patiënt A van de XXX_Toorn
- 1.1 Patiënt J de XXX_Rover
1 Addenda voor inhoudelijke gegevens
1.1 Patiënt J de XXX_Rover
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | J | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | de | |||
| Achternaam | XXX_Rover | |||
| Identificatienummer | 999909204 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.1.1 Medicamenteuze behandeling MBH_300_gestopt
| Medicatieafspraak MBH_300_gestopt_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 4 maanden om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 4 maanden, tot en met T + 5 maanden | |||
| Ingangsdatum | T - 4 maanden | |||
| Einddatum | T + 5 maanden | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | |||
| Geneesmiddel - primaire code | OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_gestopt_MA_staken | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gestopt_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 10 dagen om 18:00 uur | |||
| Gebruiksperiode | Vanaf T - 4 maanden, tot en met T - 10 dagen | |||
| Ingangsdatum | T - 4 maanden | |||
| Einddatum | T - 10 dagen | |||
| MedicatieafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | |||
| RedenWijzigenOfStaken | geneesmiddelinteractie (code = '79899007' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gestopt_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gestopt_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 4 maanden om 09:00 uur | |||
| Gebruiksperiode | Vanaf T - 4 maanden, tot en met T + 5 maanden | |||
| Ingangsdatum | T - 4 maanden | |||
| Einddatum | T + 5 maanden | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | OMEPRAZOL SANDOZ CAPSULE MSR 20MG (code = '1500570' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gestopt_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gestopt_TA_staken | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gestopt_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 10 dagen om 19:00 uur | |||
| Gebruiksperiode | Vanaf T - 4 maanden, tot en met T - 10 dagen | |||
| Ingangsdatum | T - 4 maanden | |||
| Einddatum | T - 10 dagen | |||
| ToedieningsafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | OMEPRAZOL SANDOZ CAPSULE MSR 20MG (code = '1500570' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL 20MG CAPSULE MSR (code = '60062' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL 20MG CAPSULE MSR (code = '114529' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gestopt_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_gestopt_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_gestopt (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.1.2 Medicamenteuze behandeling MBH_300_gewijzigd
| Medicatieafspraak MBH_300_gewijzigd_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 21 dagen om 08:02 uur | |||
| Gebruiksperiode | Vanaf T - 21 dagen | |||
| Ingangsdatum | T - 21 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | |||
| Geneesmiddel - primaire code | METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_gewijzigd_MA_wijziging | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 2 dagen om 08:02 uur | |||
| Gebruiksperiode | Vanaf T - 2 dagen | |||
| Ingangsdatum | T - 2 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | |||
| RedenWijzigenOfStaken | gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 2 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 2 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_gewijzigd_MA_techstaken | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 2 dagen om 08:02 uur | |||
| Gebruiksperiode | Vanaf T - 21 dagen, tot en met T - 3 dagen | |||
| Ingangsdatum | T - 21 dagen | |||
| Einddatum | T - 3 dagen | |||
| MedicatieafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | |||
| Geneesmiddel - primaire code | METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gewijzigd_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 21 dagen om 09:02 uur | |||
| Gebruiksperiode | Vanaf T - 21 dagen | |||
| Ingangsdatum | T - 21 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gewijzigd_TA_wijziging | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 2 dagen om 09:02 uur | |||
| Gebruiksperiode | Vanaf T - 2 dagen | |||
| Ingangsdatum | T - 2 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 2 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 2 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigd_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gewijzigd_TA_techstaken | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 2 dagen om 09:02 uur | |||
| Gebruiksperiode | Vanaf T - 21 dagen, tot en met T - 3 dagen | |||
| Ingangsdatum | T - 21 dagen | |||
| Einddatum | T - 3 dagen | |||
| ToedieningsafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigd_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatietoediening MBH_300_gewijzigd_MTD1 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_MTD1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
| RegistratieDatumTijd | T - 3 dagen om 07:14:44 uur | |||
| ToedieningsDatumTijd | T - 3 dagen om 07:14:44 uur | |||
| ToegediendeHoeveelheid | ||||
| Aantal | 1 | |||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Toediener | ||||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | |||
| Geneesmiddel - primaire code | METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatietoediening MBH_300_gewijzigd_MTD2 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_MTD2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
| RegistratieDatumTijd | T - 2 dagen om 07:10:26 uur | |||
| ToedieningsDatumTijd | T - 2 dagen om 07:10:26 uur | |||
| ToegediendeHoeveelheid | ||||
| Aantal | 1 | |||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Toediener | ||||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | |||
| Geneesmiddel - primaire code | METOPROLOLSUCCINAAT MYLAN RET 100 TABL MVA 95MG (code = '2069474' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '26190' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | METOPROLOL 100MG TB MGA SUC (code = '71013' in codeSystem 'G-Standaard GPK') | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_gewijzigd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_gewijzigd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.1.3 Medicamenteuze behandeling MBH_300_gewijzigddoorander
| Medicatieafspraak MBH_300_gewijzigddoorander_MA_eigen | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 60 dagen om 08:05 uur | |||
| Gebruiksperiode | Vanaf T - 60 dagen, tot en met T + 14 dagen | |||
| Ingangsdatum | T - 60 dagen | |||
| Einddatum | T + 14 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | |||
| Geneesmiddel - primaire code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_gewijzigddoorander_MA_wijzigingdoorander | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 3 dagen om 08:10 uur | |||
| Gebruiksperiode | Vanaf T - 3 dagen, tot en met T + 30 dagen | |||
| Ingangsdatum | T - 3 dagen | |||
| Einddatum | T + 30 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| RedenWijzigenOfStaken | gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 2 stuks, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 2 stuks | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_gewijzigddoorander_MA_techstakendoorander | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigddoorander_MA_techstakendoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 3 dagen om 08:10 uur | |||
| Gebruiksperiode | Vanaf T - 60 dagen, tot en met T - 4 dagen | |||
| Ingangsdatum | T - 60 dagen | |||
| Einddatum | T - 4 dagen | |||
| MedicatieafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gewijzigddoorander_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigddoorander_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 60 dagen om 09:05 uur | |||
| Gebruiksperiode | Vanaf T - 60 dagen, tot en met T + 14 dagen | |||
| Ingangsdatum | T - 60 dagen | |||
| Einddatum | T + 14 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gewijzigddoorander_TA_wijziging | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigddoorander_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 3 dagen om 09:10 uur | |||
| Gebruiksperiode | Vanaf T - 3 dagen, tot en met T + 30 dagen | |||
| Ingangsdatum | T - 3 dagen | |||
| Einddatum | T + 30 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 2 stuks, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 2 stuks | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gewijzigddoorander_TA_techstaken | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigddoorander_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 3 dagen om 09:10 uur | |||
| Gebruiksperiode | Vanaf T - 60 dagen, tot en met T - 4 dagen | |||
| Ingangsdatum | T - 60 dagen | |||
| Einddatum | T - 4 dagen | |||
| ToedieningsafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigddoorander_MA_techstakendoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_gewijzigddoorander_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_gewijzigddoorander_MGB_zv | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigddoorander_MGB_zv (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| MedicatiegebruikDatumTijd | T - 3 dagen om 08:08 uur | |||
| GebruikIndicator | Ja | |||
| VolgensAfspraakIndicator | Ja | |||
| Gebruiksperiode | Vanaf T - 60 dagen, tot en met T - 3 dagen | |||
| Ingangsdatum | T - 60 dagen | |||
| Einddatum | T - 3 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | |||
| Informant | ||||
| InformantIsPatient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigddoorander_MA_eigen (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_gewijzigddoorander_MGB_pat | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigddoorander_MGB_pat (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| MedicatiegebruikDatumTijd | T om 08:08 uur | |||
| GebruikIndicator | Ja | |||
| VolgensAfspraakIndicator | Ja | |||
| Gebruiksperiode | Vanaf T - 3 dagen, tot en met T - 1 dag | |||
| Ingangsdatum | T - 3 dagen | |||
| Einddatum | T - 1 dag | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Auteur | ||||
| AuteurIsPatient | Ja | |||
| Geneesmiddel - primaire code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 2 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 2 stuks | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigddoorander_MA_wijzigingdoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gewijzigddoorander (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.1.4 Medicamenteuze behandeling MBH_300_onderbroken
| Medicatieafspraak MBH_300_onderbroken_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 153 dagen om 08:06 uur | |||
| Gebruiksperiode | Vanaf T - 153 dagen, tot en met T + 20 dagen | |||
| Ingangsdatum | T - 153 dagen | |||
| Einddatum | T + 20 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | |||
| Geneesmiddel - primaire code | FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_onderbroken_MA_onderbreken | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_onderbroken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 100 dagen om 18:12 uur | |||
| Gebruiksperiode | Vanaf T - 153 dagen, tot en met T - 100 dagen | |||
| Ingangsdatum | T - 153 dagen | |||
| Einddatum | T - 100 dagen | |||
| MedicatieafspraakStopType | onderbroken (code = '385655000' in codeSystem 'SNOMED CT') | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | |||
| RedenWijzigenOfStaken | verrichting gepland (code = '405613005' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_onderbroken_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_onderbroken_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 153 dagen om 09:06 uur | |||
| Gebruiksperiode | Vanaf T - 153 dagen, tot en met T + 20 dagen | |||
| Ingangsdatum | T - 153 dagen | |||
| Einddatum | T + 20 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | FUROSEMIDE CF TABLET 20MG (code = '1099469' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_onderbroken_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_onderbroken_TA_onderbreken | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_onderbroken_TA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 100 dagen om 19:12 uur | |||
| Gebruiksperiode | Vanaf T - 153 dagen, tot en met T - 100 dagen | |||
| Ingangsdatum | T - 153 dagen | |||
| Einddatum | T - 100 dagen | |||
| ToedieningsafspraakStopType | onderbroken (code = '385655000' in codeSystem 'SNOMED CT') | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | FUROSEMIDE CF TABLET 20MG (code = '1099469' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | FUROSEMIDE 20MG TABLET (code = '3387' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FUROSEMIDE 20MG TABLET (code = '10995' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_onderbroken_MA_onderbreken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_onderbroken_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_onderbroken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.1.5 Medicamenteuze behandeling MBH_300_andermans1
| Medicatieafspraak MBH_300_andermans1_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_andermans1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 10 dagen om 18:05 uur | |||
| Gebruiksperiode | Vanaf T - 9 dagen, tot en met T + 15 dagen | |||
| Ingangsdatum | T - 9 dagen | |||
| Einddatum | T + 15 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: JAN_VAN_HARTEN | |||
| Geneesmiddel - primaire code | PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_andermans1_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_andermans1_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 10 dagen om 18:45 uur | |||
| Gebruiksperiode | Vanaf T - 9 dagen, tot en met T + 15 dagen | |||
| Ingangsdatum | T - 9 dagen | |||
| Einddatum | T + 15 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | PANTOPRAZOL TEVA TABLET MSR 20MG (code = '2002914' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_andermans1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_andermans1_MGB_zv | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_andermans1_MGB_zv (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| MedicatiegebruikDatumTijd | T om 08:08 uur | |||
| GebruikIndicator | Ja | |||
| VolgensAfspraakIndicator | Ja | |||
| Gebruiksperiode | Vanaf T - 9 dagen, tot en met T | |||
| Ingangsdatum | T - 9 dagen | |||
| Einddatum | T | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: JAN_VAN_HARTEN | |||
| Informant | ||||
| InformantIsPatient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: JAN_VAN_HARTEN | |||
| Geneesmiddel - primaire code | PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_andermans1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_andermans1_MGB_pat | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_andermans1_MGB_pat (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| MedicatiegebruikDatumTijd | T om 18:08 uur | |||
| GebruikIndicator | Ja | |||
| VolgensAfspraakIndicator | Ja | |||
| Gebruiksperiode | Vanaf T - 9 dagen, tot en met T | |||
| Ingangsdatum | T - 9 dagen | |||
| Einddatum | T | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: JAN_VAN_HARTEN | |||
| Auteur | ||||
| AuteurIsPatient | Ja | |||
| Geneesmiddel - primaire code | PANTOPRAZOL 20MG TABLET MSR (code = '52272' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | PANTOPRAZOL 20MG TABLET MSR (code = '106275' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 2 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 2 stuks | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_eigen1_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_andermans1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.1.6 Medicamenteuze behandeling MBH_300_andermans2
| Medicatieafspraak MBH_300_andermans2_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_andermans2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 159 dagen om 08:15 uur | |||
| Gebruiksperiode | Vanaf T - 159 dagen, gedurende 1 week | |||
| Ingangsdatum | T - 159 dagen | |||
| Gebruiksduur | 1 week | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: JAN_VAN_HARTEN | |||
| Geneesmiddel - primaire code | AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 3 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 3 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_andermans2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_andermans2_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_andermans2_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 159 dagen om 09:15 uur | |||
| Gebruiksperiode | Vanaf T - 159 dagen, gedurende 1 week | |||
| Ingangsdatum | T - 159 dagen | |||
| Gebruiksduur | 1 week | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | AMOXICILLINE DISPER SANDOZ TABLET 500MG (code = '802891' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '68519' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | AMOXICILLINE DISPERTABLET 500MG (code = '117080' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 3 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 3 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_eigen2_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_andermans2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.1.7 Medicamenteuze behandeling MBH_300_geannuleerd
| Medicatieafspraak MBH_300_geannuleerd_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_geannuleerd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 2 dagen om 18:15 uur | |||
| Gebruiksperiode | Vanaf T + 5 dagen | |||
| Ingangsdatum | T + 5 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | |||
| Geneesmiddel - primaire code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 2 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 2 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_geannuleerd_MA_annuleren | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_geannuleerd_MA_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 1 dag om 15:30 uur | |||
| Gebruiksperiode | Vanaf T + 5 dagen, tot en met T + 5 dagen om 00:00 uur | |||
| Ingangsdatum | T + 5 dagen | |||
| Einddatum | T + 5 dagen om 00:00 uur | |||
| MedicatieafspraakStopType | geannuleerd (code = '89925002' in codeSystem 'SNOMED CT') | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | |||
| RedenWijzigenOfStaken | medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 2 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard ') | |||
| Doseerinstructie | 2 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_geannuleerd_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_geannuleerd_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_geannuleerd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 2 dagen om 19:05 uur | |||
| Gebruiksperiode | Vanaf T + 5 dagen | |||
| Ingangsdatum | T + 5 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_JANSEN_EN_CO | |||
| Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 2 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 2 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_andermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_geannuleerd_TA_annuleren | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_geannuleerd_TA_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 1 dag om 16:45 uur | |||
| Gebruiksperiode | Vanaf T + 5 dagen, tot en met T + 5 dagen om 00:00 uur | |||
| Ingangsdatum | T + 5 dagen | |||
| Einddatum | T + 5 dagen om 00:00 uur | |||
| ToedieningsafspraakStopType | geannuleerd (code = '89925002' in codeSystem 'SNOMED CT') | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_JANSEN_EN_CO | |||
| ToedieningsafspraakRedenWijzigenOfStaken | medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | IBUPROFEN PCH TABLET 600MG (code = '641898' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '17469' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 600MG (code = '42080' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 2 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 2 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_geannuleerd_MA_annuleren (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_geannuleerd_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_geannuleerd (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.1.8 Medicamenteuze behandeling MBH_300_toekomstig
| Medicatieafspraak MBH_300_toekomstig_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_toekomstig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 1 dag om 08:15 uur | |||
| Gebruiksperiode | Vanaf T + 15 dagen, tot en met T + 51 dagen | |||
| Ingangsdatum | T + 15 dagen | |||
| Einddatum | T + 51 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | |||
| Geneesmiddel - primaire code | DOXYCYCLINE 100MG TABLET (code = '19844' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DOXYCYCLINE 100MG TABLET (code = '22179' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_toekomstig_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_toekomstig_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 1 dag om 09:15 uur | |||
| Gebruiksperiode | Vanaf T + 15 dagen, tot en met T + 51 dagen | |||
| Ingangsdatum | T + 15 dagen | |||
| Einddatum | T + 51 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | DOXYCYCLINE PCH TABLET 100MG (code = '1141317' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | DOXYCYCLINE 100MG TABLET (code = '19844' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DOXYCYCLINE 100MG TABLET (code = '22179' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_toekomstig_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_toekomstig (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.1.9 Medicamenteuze behandeling MBH_300_gestoptandermans
| Medicatieafspraak MBH_300_gestoptandermans_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 20 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen, tot en met T + 7 dagen | |||
| Ingangsdatum | T - 20 dagen | |||
| Einddatum | T + 7 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_gestoptandermans_MA_staken | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gestoptandermans_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 10 dagen om 18:00 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen, tot en met T - 10 dagen | |||
| Ingangsdatum | T - 20 dagen | |||
| Einddatum | T - 10 dagen | |||
| MedicatieafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| RedenWijzigenOfStaken | geneesmiddelinteractie (code = '79899007' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gestoptandermans_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gestoptandermans_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 20 dagen om 09:00 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen, tot en met T + 7 dagen | |||
| Ingangsdatum | T - 20 dagen | |||
| Einddatum | T + 7 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_JANSEN_EN_CO | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gestoptandermans_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gestoptandermans_TA_staken | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gestoptandermans_TA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 10 dagen om 19:00 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen, tot en met T - 10 dagen | |||
| Ingangsdatum | T - 20 dagen | |||
| Einddatum | T - 10 dagen | |||
| ToedieningsafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_JANSEN_EN_CO | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gestoptandermans_MA_staken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_gestoptandermans_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_gestoptandermans (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.1.10 Medicamenteuze behandeling MBH_300_gewijzigd_toekomst
| Medicatieafspraak MBH_300_gewijzigd_toekomst_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 11 dagen om 08:20 uur | |||
| Gebruiksperiode | Vanaf T - 11 dagen | |||
| Ingangsdatum | T - 11 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | |||
| Geneesmiddel - primaire code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 2 maal per week 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 2 maal per week 1 stuk | |||
| MBH identificatie | MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_gewijzigd_toekomst_MA_wijziging | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_toekomst_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 1 dag om 08:10 uur | |||
| Gebruiksperiode | Vanaf T + 2 dagen | |||
| Ingangsdatum | T + 2 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | |||
| RedenWijzigenOfStaken | te sterk effect van medicatie (code = '112251000146103' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per week 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per week 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_gewijzigd_toekomst_MA_techstaken | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_toekomst_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 1 dag om 08:10 uur | |||
| Gebruiksperiode | Vanaf T - 11 dagen, tot en met T + 1 dag om 00:00 uur | |||
| Ingangsdatum | T - 11 dagen | |||
| Einddatum | T + 1 dag om 00:00 uur | |||
| MedicatieafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | |||
| Geneesmiddel - primaire code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 2 maal per week 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 2 maal per week 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gewijzigd_toekomst_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_toekomst_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 11 dagen om 10:30 uur | |||
| Gebruiksperiode | Vanaf T - 11 dagen | |||
| Ingangsdatum | T - 11 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 2 maal per week 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 2 maal per week 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gewijzigd_toekomst_TA_wijziging | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_toekomst_TA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 1 dag om 11:10 uur | |||
| Gebruiksperiode | Vanaf T + 2 dagen | |||
| Ingangsdatum | T + 2 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| ToedieningsafspraakRedenWijzigenOfStaken | te sterk effect van medicatie (code = '112251000146103' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per week 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per week 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigd_toekomst_MA_wijziging (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | 2.16.840.1.113883.2.4.3.11.999.77.16076005.1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_gewijzigd_toekomst_TA_techstaken | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_toekomst_TA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 1 dag om 11:10 uur | |||
| Gebruiksperiode | Vanaf T - 11 dagen, tot en met T + 1 dag om 00:00 uur | |||
| Ingangsdatum | T - 11 dagen | |||
| Einddatum | T + 1 dag om 00:00 uur | |||
| ToedieningsafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 2 maal per week 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 2 maal per week 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigd_toekomst_MA_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_gewijzigd_toekomst_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatietoediening MBH_300_gewijzigd_toekomst_MTD1 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_toekomst_MTD1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
| RegistratieDatumTijd | T - 5 dagen om 08:14:44 uur | |||
| ToedieningsDatumTijd | T - 5 dagen om 08:14:44 uur | |||
| ToegediendeHoeveelheid | ||||
| Aantal | 1 | |||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Toediener | ||||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | |||
| Geneesmiddel - primaire code | FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_gewijzigd_toekomst_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| MBH identificatie | MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatietoediening MBH_300_gewijzigd_toekomst_MTD2 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gewijzigd_toekomst_MTD2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
| RegistratieDatumTijd | T om 07:15:23 uur | |||
| ToedieningsDatumTijd | T om 07:15:23 uur | |||
| ToegediendeHoeveelheid | ||||
| Aantal | 1 | |||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Toediener | ||||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | |||
| Geneesmiddel - primaire code | FERROFUMARAAT TEVA TABLET 200MG (code = '869244' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '42293' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | FERROFUMARAAT TABLET 200MG (code = '15342' in codeSystem 'G-Standaard GPK') | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_gewijzigd_toekomst_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_gewijzigd_toekomst_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| MBH identificatie | MBH_300_gewijzigd_toekomst (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
1.1.11 Medicamenteuze behandeling MBH_300_gebruik
| Medicatiegebruik MBH_300_gebruik_MGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_gebruik_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| MedicatiegebruikDatumTijd | T - 1 dag om 08:12 uur | |||
| GebruikIndicator | Ja | |||
| Gebruiksperiode | Vanaf T - 10 dagen, tot en met T - 2 dagen | |||
| Ingangsdatum | T - 10 dagen | |||
| Einddatum | T - 2 dagen | |||
| Auteur | ||||
| AuteurIsPatient | Ja | |||
| Geneesmiddel - ProductSpecificatie | ||||
| ProductNaam | Paracetamol 500mg | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_gebruik (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener JAN_VAN_HARTEN | ||||
| ZorgverlenerIdentificatienummer | 000002222 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Jan van Harten | |||
| Specialisme | Medisch specialisten, chirurgie (code = '0303' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: ZIEKENHUIS_HET_GELE_HART | |||
| Zorgverlener JANTIEN_TOEDIEN | ||||
| ZorgverlenerIdentificatienummer | 222220000 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Jantien Toedien | |||
| Specialisme | Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: THUISZORG_OM_EN_BIJ | |||
| Zorgverlener MARCHA_VAN_PARTNERS | ||||
| ZorgverlenerIdentificatienummer | 000001115 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Marcha van Partners | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_ITIS | |||
| Zorgverlener PETER_VAN_PULVER | ||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Peter van Pulver | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | ||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Apotheek De Gulle Gaper | |||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
| Zorgaanbieder APOTHEEK_JANSEN_EN_CO | ||||
| ZorgaanbiederIdentificatienummer | 99901111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Apotheek Jansen en Co | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_ITIS | ||||
| ZorgaanbiederIdentificatienummer | 00005111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Itis | |||
| Adresgegevens | Werkadres: Langelaan 1 1234ZZ Onze Stad | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | |||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
| Zorgaanbieder THUISZORG_OM_EN_BIJ | ||||
| ZorgaanbiederIdentificatienummer | 11110000 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Thuiszorg Om en Bij | |||
| OrganisatieType | Thuiszorg (code = 'T2' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | |||
| Zorgaanbieder ZIEKENHUIS_HET_GELE_HART | ||||
| ZorgaanbiederIdentificatienummer | 00004444 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Ziekenhuis het Gele Hart | |||
| Adresgegevens | Werkadres: Groenestraat 1 1200AA Hartstad | |||
| OrganisatieType | Ziekenhuis (code = 'V4' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | |||
1.2 Patiënt J XXX_Vriends
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | J | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Vriends | |||
| Identificatienummer | 999909216 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.2.1 Medicamenteuze behandeling MBH_300_NieuweMA
| Medicatieafspraak MBH_300_NieuweMA_start_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 289 dagen om 11:30 uur | |||
| Gebruiksperiode | Vanaf T - 289 dagen | |||
| Ingangsdatum | T - 289 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_NieuweMA_stop_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_NieuweMA_stop_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 70 dagen om 13:45 uur | |||
| Gebruiksperiode | Vanaf T - 289 dagen, tot en met T - 71 dagen | |||
| Ingangsdatum | T - 289 dagen | |||
| Einddatum | T - 71 dagen | |||
| MedicatieafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| RedenWijzigenOfStaken | medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_NieuweMA_nieuw_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 30 dagen om 10:45 uur | |||
| Gebruiksperiode | Vanaf T - 30 dagen | |||
| Ingangsdatum | T - 30 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_NieuweMA_start_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_NieuweMA_start_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 289 dagen om 11:31 uur | |||
| Gebruiksperiode | Vanaf T - 289 dagen | |||
| Ingangsdatum | T - 289 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_NieuweMA_start_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_NieuweMA_stop_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_NieuweMA_stop_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 25 dagen om 15:55 uur | |||
| Gebruiksperiode | Vanaf T - 289 dagen, tot en met T - 71 dagen | |||
| Ingangsdatum | T - 289 dagen | |||
| Einddatum | T - 71 dagen | |||
| ToedieningsafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| ToedieningsafspraakRedenWijzigenOfStaken | medicatiebeleid veranderd (code = '112751000146109' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_NieuweMA_stop_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_NieuweMA_start_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_NieuweMA_nieuw_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_NieuweMA_nieuw_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 25 dagen om 15:57 uur | |||
| Gebruiksperiode | Vanaf T - 30 dagen | |||
| Ingangsdatum | T - 30 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_NieuweMA_start_MGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_NieuweMA_start_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| MedicatiegebruikDatumTijd | T - 289 dagen om 11:32 uur | |||
| GebruikIndicator | Ja | |||
| Gebruiksperiode | Vanaf T - 289 dagen | |||
| Ingangsdatum | T - 289 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Informant | ||||
| InformantIsPatient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_NieuweMA_start_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_NieuweMA_nieuw_MGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_NieuweMA_nieuw_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| MedicatiegebruikDatumTijd | T - 10 dagen om 13:30 uur | |||
| GebruikIndicator | Ja | |||
| Gebruiksperiode | Vanaf T - 30 dagen | |||
| Ingangsdatum | T - 30 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Informant | ||||
| InformantIsPatient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_NieuweMA_nieuw_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatietoediening MBH_300_NieuweMA_MTD1 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_NieuweMA_MTD1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
| RegistratieDatumTijd | T - 2 dagen om 09:00 uur | |||
| ToedieningsDatumTijd | T - 2 dagen om 09:00 uur | |||
| ToegediendeHoeveelheid | ||||
| Aantal | 1 | |||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Toediener | ||||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_NieuweMA_nieuw_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatietoediening MBH_300_NieuweMA_MTD2 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_NieuweMA_MTD2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
| RegistratieDatumTijd | T - 1 dag om 10:05 uur | |||
| ToedieningsDatumTijd | T - 1 dag om 10:05 uur | |||
| ToegediendeHoeveelheid | ||||
| Aantal | 1 | |||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Toediener | ||||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_NieuweMA_nieuw_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatietoediening MBH_300_NieuweMA_MTD3 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_NieuweMA_MTD3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
| RegistratieDatumTijd | T - 1 dag om 10:10 uur | |||
| ToedieningsDatumTijd | T - 1 dag om 10:10 uur | |||
| ToegediendeHoeveelheid | ||||
| Aantal | -1 | |||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Toediener | ||||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | |||
| MedicatietoedieningRedenVanAfwijken | medicatie uitgespuugd door patiënt (code = '152741000146103' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_NieuweMA_nieuw_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatietoediening MBH_300_NieuweMA_MTD4 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_NieuweMA_MTD4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
| RegistratieDatumTijd | T - 1 dag om 11:30 uur | |||
| ToedieningsDatumTijd | T - 1 dag om 11:30 uur | |||
| ToegediendeHoeveelheid | ||||
| Aantal | 1 | |||
| Eenheid | stuk (code = '245' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Toediener | ||||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_NieuweMA_nieuw_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_NieuweMA_nieuw_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_NieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener JANTIEN_TOEDIEN | ||||
| ZorgverlenerIdentificatienummer | 222220000 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Jantien Toedien | |||
| Specialisme | Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: THUISZORG_OM_EN_BIJ | |||
| Zorgverlener PETER_VAN_PULVER | ||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Peter van Pulver | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | ||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Apotheek De Gulle Gaper | |||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | |||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
| Zorgaanbieder THUISZORG_OM_EN_BIJ | ||||
| ZorgaanbiederIdentificatienummer | 11110000 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Thuiszorg Om en Bij | |||
| OrganisatieType | Thuiszorg (code = 'T2' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | |||
1.3 Patiënt J van de XXX_Lans
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | J | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Lans | |||
| Identificatienummer | 999909228 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.3.1 Medicamenteuze behandeling MBH_300_OTCmedicatie
| Medicatieafspraak MBH_300_OTCmedicatie_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_OTCmedicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 30 dagen om 10:45 uur | |||
| Gebruiksperiode | Vanaf T - 30 dagen, tot en met T - 16 dagen | |||
| Ingangsdatum | T - 30 dagen | |||
| Einddatum | T - 16 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 2 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 2 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_OTCmedicatie_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_OTCmedicatie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 28 dagen om 14:35 uur | |||
| Gebruiksperiode | Vanaf T - 28 dagen, tot en met T - 14 dagen om 00:00 uur | |||
| Ingangsdatum | T - 28 dagen | |||
| Einddatum | T - 14 dagen om 00:00 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 2 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 2 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_OTCmedicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_OTCmedicatie_MGB_oud1 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_OTCmedicatie_MGB_oud1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| MedicatiegebruikDatumTijd | T - 270 dagen om 16:03 uur | |||
| GebruikIndicator | Ja | |||
| Gebruiksperiode | Vanaf T - 280 dagen, tot en met T - 273 dagen | |||
| Ingangsdatum | T - 280 dagen | |||
| Einddatum | T - 273 dagen | |||
| Informant | ||||
| InformantIsPatient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_OTCmedicatie_MGB_oud2 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_OTCmedicatie_MGB_oud2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| MedicatiegebruikDatumTijd | T - 150 dagen om 11:59 uur | |||
| GebruikIndicator | Ja | |||
| Gebruiksperiode | Vanaf T - 155 dagen, tot en met T - 147 dagen | |||
| Ingangsdatum | T - 155 dagen | |||
| Einddatum | T - 147 dagen | |||
| Informant | ||||
| InformantIsPatient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 3 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 3 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_OTCmedicatie_MGB_oud3 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_OTCmedicatie_MGB_oud3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| MedicatiegebruikDatumTijd | T - 29 dagen om 09:22 uur | |||
| GebruikIndicator | Ja | |||
| Gebruiksperiode | Vanaf T - 80 dagen, tot en met T - 75 dagen | |||
| Ingangsdatum | T - 80 dagen | |||
| Einddatum | T - 75 dagen | |||
| Informant | ||||
| InformantIsPatient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_OTCmedicatie_MGB_nieuw | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_OTCmedicatie_MGB_nieuw (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| MedicatiegebruikDatumTijd | T - 16 dagen om 14:45 uur | |||
| GebruikIndicator | Ja | |||
| Gebruiksperiode | Vanaf T - 28 dagen, tot en met T - 14 dagen | |||
| Ingangsdatum | T - 28 dagen | |||
| Einddatum | T - 14 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Informant | ||||
| InformantIsPatient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | IBUPROFEN SAM TABLET OMHULD 200MG (code = '2597039' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 200MG (code = '27251' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | IBUPROFEN TABLET 200MG (code = '50997' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 2 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 2 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_OTCmedicatie_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_OTCmedicatie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener PETER_VAN_PULVER | ||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Peter van Pulver | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | ||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Apotheek De Gulle Gaper | |||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | |||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
1.4 Patiënt J van XXX_Noort
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | J | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van | |||
| Achternaam | XXX_Noort | |||
| Identificatienummer | 999909241 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.4.1 Medicamenteuze behandeling MBH_300_ToekomstigEnNieuweMA
| Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_startMA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 98 dagen om 15:11 uur | |||
| Gebruiksperiode | Vanaf T - 98 dagen, gedurende 50 dagen | |||
| Ingangsdatum | T - 98 dagen | |||
| Gebruiksduur | 50 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 2 maal per dag 2 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 2 maal per dag 2 stuks | |||
| MBH identificatie | MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_ToekomstMA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_ToekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 70 dagen om 14:44 uur | |||
| Gebruiksperiode | Vanaf T + 10 dagen | |||
| Ingangsdatum | T + 10 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 3 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 3 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_stopMA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 63 dagen om 09:13 uur | |||
| Gebruiksperiode | Vanaf T - 98 dagen, tot en met T - 63 dagen | |||
| Ingangsdatum | T - 98 dagen | |||
| Einddatum | T - 63 dagen | |||
| MedicatieafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 2 maal per dag 2 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 2 maal per dag 2 stuks | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_ToekomstigEnNieuweMA_NieuwMA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_NieuwMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 63 dagen om 09:15 uur | |||
| Gebruiksperiode | Vanaf T - 30 dagen, tot en met T + 9 dagen | |||
| Ingangsdatum | T - 30 dagen | |||
| Einddatum | T + 9 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 39 dagen 2 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | gedurende 39 dagen 2 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_ToekomstigEnNieuweMA_startTA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_startTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 98 dagen om 15:15 uur | |||
| Gebruiksperiode | Vanaf T - 98 dagen | |||
| Ingangsdatum | T - 98 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 2 maal per dag 2 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 2 maal per dag 2 stuks | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_ToekomstigEnNieuweMA_ToekomstTA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_ToekomstTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 70 dagen om 14:45 uur | |||
| Gebruiksperiode | Vanaf T + 10 dagen | |||
| Ingangsdatum | T + 10 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 3 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 3 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_ToekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_ToekomstigEnNieuweMA_startMGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_startMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| MedicatiegebruikDatumTijd | T - 98 dagen om 15:20 uur | |||
| GebruikIndicator | Ja | |||
| Gebruiksperiode | Vanaf T - 98 dagen | |||
| Ingangsdatum | T - 98 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Informant | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 2 maal per dag 2 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 2 maal per dag 2 stuks | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_ToekomstigEnNieuweMA_ToekomstMGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_ToekomstMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| MedicatiegebruikDatumTijd | T - 70 dagen om 14:50 uur | |||
| GebruikIndicator | Ja | |||
| Gebruiksperiode | Vanaf T + 10 dagen | |||
| Ingangsdatum | T + 10 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Informant | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | OMEPRAZOL AURO CAPSULE MSR 10MG (code = '1544977' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL CAPSULE MSR 10MG (code = '60054' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | OMEPRAZOL CAPSULE MSR 10MG (code = '115142' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 3 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 3 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_ToekomstigEnNieuweMA_ToekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_ToekomstigEnNieuweMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener PETER_VAN_PULVER | ||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Peter van Pulver | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | ||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Apotheek De Gulle Gaper | |||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | |||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
1.5 Patiënt j XXX_Schoutens
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | j | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Schoutens | |||
| Identificatienummer | 999909253 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.5.1 Medicamenteuze behandeling MBH_300_nieuweToekomstigeMA
| Medicatieafspraak MBH_300_nieuweToekomstigeMA_startMA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_nieuweToekomstigeMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 20 dagen om 10:01 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen, gedurende 3 weken | |||
| Ingangsdatum | T - 20 dagen | |||
| Gebruiksduur | 3 weken | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 3 weken 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | gedurende 3 weken 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_nieuweToekomstigeMA_toekomstMA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 15 dagen om 13:26 uur | |||
| Gebruiksperiode | Vanaf T + 1 dag, gedurende 1 week | |||
| Ingangsdatum | T + 1 dag | |||
| Gebruiksduur | 1 week | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 1 week 1 maal per dag 3 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | gedurende 1 week 1 maal per dag 3 stuks | |||
| MBH identificatie | MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_nieuweToekomstigeMA_annuleerMA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_nieuweToekomstigeMA_annuleerMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 5 dagen om 15:15 uur | |||
| Gebruiksperiode | Vanaf T + 1 dag, tot en met T + 1 dag om 00:00 uur | |||
| Ingangsdatum | T + 1 dag | |||
| Einddatum | T + 1 dag om 00:00 uur | |||
| MedicatieafspraakStopType | geannuleerd (code = '89925002' in codeSystem 'SNOMED CT') | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 1 week 1 maal per dag 3 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | gedurende 1 week 1 maal per dag 3 stuks | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_nieuweToekomstigeMA_nieuwMA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_nieuweToekomstigeMA_nieuwMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 5 dagen om 15:20 uur | |||
| Gebruiksperiode | Vanaf T + 1 dag, gedurende 4 dagen | |||
| Ingangsdatum | T + 1 dag | |||
| Gebruiksduur | 4 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| RedenWijzigenOfStaken | foutieve registratie van medicatie (code = '159691000146109' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 4 dagen 1 maal per dag 2 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | gedurende 4 dagen 1 maal per dag 2 stuks | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_nieuweToekomstigeMA_startTA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_nieuweToekomstigeMA_startTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 20 dagen om 10:05 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen, gedurende 3 weken | |||
| Ingangsdatum | T - 20 dagen | |||
| Gebruiksduur | 3 weken | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 3 weken 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | gedurende 3 weken 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_nieuweToekomstigeMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_nieuweToekomstigeMA_toekomstTA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_nieuweToekomstigeMA_toekomstTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 15 dagen om 13:30 uur | |||
| Gebruiksperiode | Vanaf T + 1 dag, gedurende 1 week | |||
| Ingangsdatum | T + 1 dag | |||
| Gebruiksduur | 1 week | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 1 week 1 maal per dag 3 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | gedurende 1 week 1 maal per dag 3 stuks | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_nieuweToekomstigeMA_startMGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_nieuweToekomstigeMA_startMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| MedicatiegebruikDatumTijd | T - 20 dagen om 10:10 uur | |||
| GebruikIndicator | Ja | |||
| Gebruiksperiode | Vanaf T - 20 dagen, gedurende 3 weken | |||
| Ingangsdatum | T - 20 dagen | |||
| Gebruiksduur | 3 weken | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Informant | ||||
| InformantIsPatient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 3 weken 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | gedurende 3 weken 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_nieuweToekomstigeMA_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_nieuweToekomstigeMA_toekomstMGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_nieuweToekomstigeMA_toekomstMGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| MedicatiegebruikDatumTijd | T - 15 dagen om 13:35 uur | |||
| GebruikIndicator | Ja | |||
| Gebruiksperiode | Vanaf T + 1 dag, gedurende 1 week | |||
| Ingangsdatum | T + 1 dag | |||
| Gebruiksduur | 1 week | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Informant | ||||
| InformantIsPatient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | ATORVASTATINE TEVA TABLET FILMOMHULD 10MG (code = '2198088' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '98604' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ATORVASTATINE 10MG TABLET (code = '137197' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | gedurende 1 week 1 maal per dag 3 stuks, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | gedurende 1 week 1 maal per dag 3 stuks | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_nieuweToekomstigeMA_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_nieuweToekomstigeMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener PETER_VAN_PULVER | ||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Peter van Pulver | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | ||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Apotheek De Gulle Gaper | |||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | |||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
1.6 Patiënt J de XXX_Groote
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | J | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | de | |||
| Achternaam | XXX_Groote | |||
| Identificatienummer | 999909265 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.6.1 Medicamenteuze behandeling MBH_300_stopMA_zonder_referentie
| Medicatieafspraak MBH_300_stopMA_zonder_referentie_stopMA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_stopMA_zonder_referentie_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 5 dagen om 13:55 uur | |||
| Gebruiksperiode | Vanaf T - 14 dagen, tot en met T - 5 dagen | |||
| Ingangsdatum | T - 14 dagen | |||
| Einddatum | T - 5 dagen | |||
| MedicatieafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_stopMA_zonder_referentie_startMA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_stopMA_zonder_referentie_startMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 5 dagen om 13:57 uur | |||
| Gebruiksperiode | Vanaf T - 5 dagen, tot en met T + 2 dagen | |||
| Ingangsdatum | T - 5 dagen | |||
| Einddatum | T + 2 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1.5 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1.5 stuk | |||
| MBH identificatie | MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_stopMA_zonder_referentie_toekomstMA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_stopMA_zonder_referentie_toekomstMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 5 dagen om 14:03 uur | |||
| Gebruiksperiode | Vanaf T + 3 dagen, gedurende 3 dagen | |||
| Ingangsdatum | T + 3 dagen | |||
| Gebruiksduur | 3 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_stopMA_zonder_referentie_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_stopMA_zonder_referentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 14 dagen om 15:14 uur | |||
| Gebruiksperiode | Vanaf T - 14 dagen, tot en met T + 2 dagen | |||
| Ingangsdatum | T - 14 dagen | |||
| Einddatum | T + 2 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| MBH identificatie | MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatiegebruik MBH_300_stopMA_zonder_referentie_MGB | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_stopMA_zonder_referentie_MGB (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.6.1) | |||
| MedicatiegebruikDatumTijd | T - 14 dagen om 15:20 uur | |||
| GebruikIndicator | Ja | |||
| Gebruiksperiode | Vanaf T - 14 dagen, tot en met T + 2 dagen | |||
| Ingangsdatum | T - 14 dagen | |||
| Einddatum | T + 2 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Informant | ||||
| InformantIsPatient | Ja | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | DICLOFENAC NATRIUM SANDOZ RETARD TABLET MGA 100MG (code = '594253' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '8052' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | DICLOFENAC NATRIUM TABLET MGA 100MG (code = '22268' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 stuk, oraal | |||
| Toedieningsweg | oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie | 1 maal per dag 1 stuk | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_stopMA_zonder_referentie_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_stopMA_zonder_referentie (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener PETER_VAN_PULVER | ||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Peter van Pulver | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | ||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Apotheek De Gulle Gaper | |||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | |||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
1.7 Patiënt H XXX_Snijdewint
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | H | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Snijdewint | |||
| Identificatienummer | 999909125 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.7.1 Medicamenteuze behandeling MBH_300_WDS
| Medicatieafspraak MBH_300_WDS_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 5 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 5 dagen om 08:00 uur | |||
| Ingangsdatum | T - 5 dagen om 08:00 uur | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Volgens schema trombosedienst, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| AanvullendeInstructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | |||
| MBH identificatie | MBH_300_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| WisselendDoseerschema MBH_300_WDS_WDS | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| RegistratieDatumTijd | T - 5 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 5 dagen om 08:00 uur, tot en met T + 2 dagen | |||
| Ingangsdatum | T - 5 dagen om 08:00 uur | |||
| Einddatum | T + 2 dagen | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: TANJA_DE_BAKKER | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | eerst gedurende 2 dagen 1 maal per dag 1 stuk, dan gedurende 1 dag 1 maal per dag 2 stuks, dan gedurende 2 dagen 1 maal per dag 1 stuk, dan gedurende 1 dag 1 maal per dag 2 stuks, dan gedurende 1 dag 1 maal per dag 1 stuk, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie 1 | eerst gedurende 2 dagen 1 maal per dag 1 stuk | |||
| Doseerinstructie 2 | dan gedurende 1 dag 1 maal per dag 2 stuks | |||
| Doseerinstructie 3 | dan gedurende 2 dagen 1 maal per dag 1 stuk | |||
| Doseerinstructie 4 | dan gedurende 1 dag 1 maal per dag 2 stuks | |||
| Doseerinstructie 5 | dan gedurende 1 dag 1 maal per dag 1 stuk | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_WDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_WDS_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 5 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 5 dagen om 08:00 uur | |||
| Ingangsdatum | T - 5 dagen om 08:00 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Volgens schema trombosedienst, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| AanvullendeInstructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_WDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener MARCHA_VAN_PARTNERS | ||||
| ZorgverlenerIdentificatienummer | 000001115 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Marcha van Partners | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_ITIS | |||
| Zorgverlener TANJA_DE_BAKKER | ||||
| ZorgverlenerIdentificatienummer | 222221111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Tanja de Bakker | |||
| Specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: TROMBOSEDIENST_ONS_DORP | |||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | ||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Apotheek De Gulle Gaper | |||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_ITIS | ||||
| ZorgaanbiederIdentificatienummer | 00005111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Itis | |||
| Adresgegevens | Werkadres: Langelaan 1 1234ZZ Onze Stad | |||
| Zorgaanbieder TROMBOSEDIENST_ONS_DORP | ||||
| ZorgaanbiederIdentificatienummer | 11112222 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Trombosedienst Ons Dorp | |||
| AfdelingSpecialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Adresgegevens | Werkadres: Kerkstraat 28 d 1332GH Ons Dorp | |||
1.8 Patiënt H XXX_Hulsing
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | H | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Hulsing | |||
| Identificatienummer | 999909137 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.8.1 Medicamenteuze behandeling MBH_300_WDS_nieuweWDS
| Medicatieafspraak MBH_300_WDS_nieuweWDS_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_nieuweWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 20 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen om 08:00 uur | |||
| Ingangsdatum | T - 20 dagen om 08:00 uur | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Volgens schema trombosedienst, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| AanvullendeInstructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | |||
| MBH identificatie | MBH_300_WDS_nieuweWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| WisselendDoseerschema MBH_300_WDS_nieuweWDS_WDS1 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_nieuweWDS_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| RegistratieDatumTijd | T - 20 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen om 08:00 uur, tot en met T - 6 dagen | |||
| Ingangsdatum | T - 20 dagen om 08:00 uur | |||
| Einddatum | T - 6 dagen | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: TANJA_DE_BAKKER | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | eerst gedurende 6 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, dan gedurende 6 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie 1 | eerst gedurende 6 dagen 1 maal per dag 3 stuks | |||
| Doseerinstructie 2 | dan gedurende 1 dag 1 maal per dag 4 stuks | |||
| Doseerinstructie 3 | dan gedurende 6 dagen 1 maal per dag 3 stuks | |||
| Doseerinstructie 4 | dan gedurende 1 dag 1 maal per dag 4 stuks | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_WDS_nieuweWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_WDS_nieuweWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| WisselendDoseerschema MBH_300_WDS_nieuweWDS_WDS2 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_nieuweWDS_WDS2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| RegistratieDatumTijd | T - 5 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 5 dagen om 08:00 uur, tot en met T + 9 dagen | |||
| Ingangsdatum | T - 5 dagen om 08:00 uur | |||
| Einddatum | T + 9 dagen | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: TANJA_DE_BAKKER | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | eerst gedurende 4 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, dan gedurende 4 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, dan gedurende 3 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie 1 | eerst gedurende 4 dagen 1 maal per dag 3 stuks | |||
| Doseerinstructie 2 | dan gedurende 1 dag 1 maal per dag 4 stuks | |||
| Doseerinstructie 3 | dan gedurende 4 dagen 1 maal per dag 3 stuks | |||
| Doseerinstructie 4 | dan gedurende 1 dag 1 maal per dag 4 stuks | |||
| Doseerinstructie 5 | dan gedurende 3 dagen 1 maal per dag 3 stuks | |||
| Doseerinstructie 6 | dan gedurende 1 dag 1 maal per dag 4 stuks | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_WDS_nieuweWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_WDS_nieuweWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_WDS_nieuweWDS_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_nieuweWDS_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 20 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen om 08:00 uur | |||
| Ingangsdatum | T - 20 dagen om 08:00 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Volgens schema trombosedienst, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| AanvullendeInstructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_WDS_nieuweWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_WDS_nieuweWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener MARCHA_VAN_PARTNERS | ||||
| ZorgverlenerIdentificatienummer | 000001115 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Marcha van Partners | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_ITIS | |||
| Zorgverlener TANJA_DE_BAKKER | ||||
| ZorgverlenerIdentificatienummer | 222221111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Tanja de Bakker | |||
| Specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: TROMBOSEDIENST_ONS_DORP | |||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | ||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Apotheek De Gulle Gaper | |||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_ITIS | ||||
| ZorgaanbiederIdentificatienummer | 00005111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Itis | |||
| Adresgegevens | Werkadres: Langelaan 1 1234ZZ Onze Stad | |||
| Zorgaanbieder TROMBOSEDIENST_ONS_DORP | ||||
| ZorgaanbiederIdentificatienummer | 11112222 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Trombosedienst Ons Dorp | |||
| AfdelingSpecialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Adresgegevens | Werkadres: Kerkstraat 28 d 1332GH Ons Dorp | |||
1.9 Patiënt I XXX_Ruha
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | I | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Ruha | |||
| Identificatienummer | 999909150 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.9.1 Medicamenteuze behandeling MBH_300_WDS_wijzigWDS
| Medicatieafspraak MBH_300_WDS_wijzigWDS_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_wijzigWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 20 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen om 08:00 uur | |||
| Ingangsdatum | T - 20 dagen om 08:00 uur | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Volgens schema trombosedienst, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| AanvullendeInstructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | |||
| MBH identificatie | MBH_300_WDS_wijzigWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| WisselendDoseerschema MBH_300_WDS_wijzigWDS_WDS1 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_wijzigWDS_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| RegistratieDatumTijd | T - 20 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen om 08:00 uur, tot en met T - 6 dagen | |||
| Ingangsdatum | T - 20 dagen om 08:00 uur | |||
| Einddatum | T - 6 dagen | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: TANJA_DE_BAKKER | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | eerst gedurende 6 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, dan gedurende 6 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie 1 | eerst gedurende 6 dagen 1 maal per dag 3 stuks | |||
| Doseerinstructie 2 | dan gedurende 1 dag 1 maal per dag 4 stuks | |||
| Doseerinstructie 3 | dan gedurende 6 dagen 1 maal per dag 3 stuks | |||
| Doseerinstructie 4 | dan gedurende 1 dag 1 maal per dag 4 stuks | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_WDS_wijzigWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_WDS_wijzigWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| WisselendDoseerschema MBH_300_WDS_wijzigWDS_WDS1_techstaken | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_wijzigWDS_WDS1_techstaken (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| RegistratieDatumTijd | T - 20 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen om 08:00 uur, tot en met T - 10 dagen | |||
| Ingangsdatum | T - 20 dagen om 08:00 uur | |||
| Einddatum | T - 10 dagen | |||
| WisselendDoseerschemaStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: TANJA_DE_BAKKER | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | eerst gedurende 6 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, dan gedurende 6 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie 1 | eerst gedurende 6 dagen 1 maal per dag 3 stuks | |||
| Doseerinstructie 2 | dan gedurende 1 dag 1 maal per dag 4 stuks | |||
| Doseerinstructie 3 | dan gedurende 6 dagen 1 maal per dag 3 stuks | |||
| Doseerinstructie 4 | dan gedurende 1 dag 1 maal per dag 4 stuks | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_WDS_wijzigWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieWisselendDoseerschema | ||||
| Identificatie | MBH_300_WDS_wijzigWDS_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| MBH identificatie | MBH_300_WDS_wijzigWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| WisselendDoseerschema MBH_300_WDS_wijzigWDS_WDS2 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_wijzigWDS_WDS2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| RegistratieDatumTijd | T - 9 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 9 dagen om 08:00 uur, tot en met T + 5 dagen | |||
| Ingangsdatum | T - 9 dagen om 08:00 uur | |||
| Einddatum | T + 5 dagen | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: TANJA_DE_BAKKER | |||
| RedenWijzigenOfStaken | gebrek aan geneesmiddeleffect (code = '58848006' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | eerst gedurende 4 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, dan gedurende 4 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, dan gedurende 3 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie 1 | eerst gedurende 4 dagen 1 maal per dag 3 stuks | |||
| Doseerinstructie 2 | dan gedurende 1 dag 1 maal per dag 4 stuks | |||
| Doseerinstructie 3 | dan gedurende 4 dagen 1 maal per dag 3 stuks | |||
| Doseerinstructie 4 | dan gedurende 1 dag 1 maal per dag 4 stuks | |||
| Doseerinstructie 5 | dan gedurende 3 dagen 1 maal per dag 3 stuks | |||
| Doseerinstructie 6 | dan gedurende 1 dag 1 maal per dag 4 stuks | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_WDS_wijzigWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieWisselendDoseerschema | ||||
| Identificatie | MBH_300_WDS_wijzigWDS_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| MBH identificatie | MBH_300_WDS_wijzigWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_WDS_wijzigWDS_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_wijzigWDS_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 20 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 20 dagen om 08:00 uur | |||
| Ingangsdatum | T - 20 dagen om 08:00 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Volgens schema trombosedienst, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| AanvullendeInstructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_WDS_wijzigWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_WDS_wijzigWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener MARCHA_VAN_PARTNERS | ||||
| ZorgverlenerIdentificatienummer | 000001115 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Marcha van Partners | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_ITIS | |||
| Zorgverlener TANJA_DE_BAKKER | ||||
| ZorgverlenerIdentificatienummer | 222221111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Tanja de Bakker | |||
| Specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: TROMBOSEDIENST_ONS_DORP | |||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | ||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Apotheek De Gulle Gaper | |||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_ITIS | ||||
| ZorgaanbiederIdentificatienummer | 00005111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Itis | |||
| Adresgegevens | Werkadres: Langelaan 1 1234ZZ Onze Stad | |||
| Zorgaanbieder TROMBOSEDIENST_ONS_DORP | ||||
| ZorgaanbiederIdentificatienummer | 11112222 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Trombosedienst Ons Dorp | |||
| AfdelingSpecialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Adresgegevens | Werkadres: Kerkstraat 28 d 1332GH Ons Dorp | |||
1.10 Patiënt K XXX_Walsmit
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | K | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Walsmit | |||
| Identificatienummer | 999909162 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.10.1 Medicamenteuze behandeling MBH_300_WDS_stopMA
| Medicatieafspraak MBH_300_WDS_stopMA_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_stopMA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 7 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 7 dagen om 08:00 uur | |||
| Ingangsdatum | T - 7 dagen om 08:00 uur | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Volgens schema trombosedienst, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| AanvullendeInstructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | |||
| MBH identificatie | MBH_300_WDS_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatieafspraak MBH_300_WDS_stopMA_stopMA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_stopMA_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 7 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 7 dagen om 08:00 uur, tot en met T - 2 dagen | |||
| Ingangsdatum | T - 7 dagen om 08:00 uur | |||
| Einddatum | T - 2 dagen | |||
| MedicatieafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | |||
| RedenWijzigenOfStaken | geneesmiddelinteractie (code = '79899007' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Volgens schema trombosedienst, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| AanvullendeInstructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_WDS_stopMA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_WDS_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| WisselendDoseerschema MBH_300_WDS_stopMA_WDS | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_stopMA_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| RegistratieDatumTijd | T - 7 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 7 dagen om 08:00 uur, tot en met T + 7 dagen | |||
| Ingangsdatum | T - 7 dagen om 08:00 uur | |||
| Einddatum | T + 7 dagen | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: TANJA_DE_BAKKER | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | eerst gedurende 6 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, dan gedurende 6 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie 1 | eerst gedurende 6 dagen 1 maal per dag 3 stuks | |||
| Doseerinstructie 2 | dan gedurende 1 dag 1 maal per dag 4 stuks | |||
| Doseerinstructie 3 | dan gedurende 6 dagen 1 maal per dag 3 stuks | |||
| Doseerinstructie 4 | dan gedurende 1 dag 1 maal per dag 4 stuks | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_WDS_stopMA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_WDS_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_WDS_stopMA_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_stopMA_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 7 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 7 dagen om 08:00 uur | |||
| Ingangsdatum | T - 7 dagen om 08:00 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Volgens schema trombosedienst, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| AanvullendeInstructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_WDS_stopMA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_WDS_stopMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener MARCHA_VAN_PARTNERS | ||||
| ZorgverlenerIdentificatienummer | 000001115 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Marcha van Partners | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_ITIS | |||
| Zorgverlener TANJA_DE_BAKKER | ||||
| ZorgverlenerIdentificatienummer | 222221111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Tanja de Bakker | |||
| Specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: TROMBOSEDIENST_ONS_DORP | |||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | ||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Apotheek De Gulle Gaper | |||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_ITIS | ||||
| ZorgaanbiederIdentificatienummer | 00005111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Itis | |||
| Adresgegevens | Werkadres: Langelaan 1 1234ZZ Onze Stad | |||
| Zorgaanbieder TROMBOSEDIENST_ONS_DORP | ||||
| ZorgaanbiederIdentificatienummer | 11112222 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Trombosedienst Ons Dorp | |||
| AfdelingSpecialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Adresgegevens | Werkadres: Kerkstraat 28 d 1332GH Ons Dorp | |||
1.11 Patiënt J XXX_Poll
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | J | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Poll | |||
| Identificatienummer | 999909174 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.11.1 Medicamenteuze behandeling MBH_300_WDS_wijzigTA
| Medicatieafspraak MBH_300_WDS_wijzigTA_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_wijzigTA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 10 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 10 dagen om 08:00 uur | |||
| Ingangsdatum | T - 10 dagen om 08:00 uur | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Volgens schema trombosedienst, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| AanvullendeInstructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | |||
| MBH identificatie | MBH_300_WDS_wijzigTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| WisselendDoseerschema MBH_300_WDS_wijzigTA_WDS | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_wijzigTA_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| RegistratieDatumTijd | T - 10 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 10 dagen om 08:00 uur, tot en met T + 4 dagen | |||
| Ingangsdatum | T - 10 dagen om 08:00 uur | |||
| Einddatum | T + 4 dagen | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: TANJA_DE_BAKKER | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | eerst gedurende 6 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, dan gedurende 6 dagen 1 maal per dag 3 stuks, dan gedurende 1 dag 1 maal per dag 4 stuks, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie 1 | eerst gedurende 6 dagen 1 maal per dag 3 stuks | |||
| Doseerinstructie 2 | dan gedurende 1 dag 1 maal per dag 4 stuks | |||
| Doseerinstructie 3 | dan gedurende 6 dagen 1 maal per dag 3 stuks | |||
| Doseerinstructie 4 | dan gedurende 1 dag 1 maal per dag 4 stuks | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_WDS_wijzigTA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_WDS_wijzigTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_WDS_wijzigTA_TA1 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_wijzigTA_TA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 10 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 10 dagen om 08:00 uur | |||
| Ingangsdatum | T - 10 dagen om 08:00 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Volgens schema trombosedienst, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| AanvullendeInstructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_WDS_wijzigTA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_WDS_wijzigTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_WDS_wijzigTA_stopTA1 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_wijzigTA_stopTA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 10 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 10 dagen om 08:00 uur, tot en met T - 5 dagen | |||
| Ingangsdatum | T - 10 dagen om 08:00 uur | |||
| Einddatum | T - 5 dagen | |||
| ToedieningsafspraakStopType | stopgezet (code = '410546004' in codeSystem 'SNOMED CT') | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Volgens schema trombosedienst, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| AanvullendeInstructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_WDS_wijzigTA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_WDS_wijzigTA_stopTA1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_WDS_wijzigTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_WDS_wijzigTA_TA2 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_wijzigTA_TA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 4 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 4 dagen om 08:00 uur | |||
| Ingangsdatum | T - 4 dagen om 08:00 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| ToedieningsafspraakRedenWijzigenOfStaken | geneesmiddel niet voorradig (code = '182856006' in codeSystem 'SNOMED CT') | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL AURO TABLET 1MG (code = '1101196' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Volgens schema trombosedienst, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| AanvullendeInstructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_WDS_wijzigTA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieToedieningsafspraak | ||||
| Identificatie | MBH_300_WDS_wijzigTA_TA2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| MBH identificatie | MBH_300_WDS_wijzigTA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener MARCHA_VAN_PARTNERS | ||||
| ZorgverlenerIdentificatienummer | 000001115 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Marcha van Partners | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_ITIS | |||
| Zorgverlener TANJA_DE_BAKKER | ||||
| ZorgverlenerIdentificatienummer | 222221111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Tanja de Bakker | |||
| Specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: TROMBOSEDIENST_ONS_DORP | |||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | ||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Apotheek De Gulle Gaper | |||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_ITIS | ||||
| ZorgaanbiederIdentificatienummer | 00005111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Itis | |||
| Adresgegevens | Werkadres: Langelaan 1 1234ZZ Onze Stad | |||
| Zorgaanbieder TROMBOSEDIENST_ONS_DORP | ||||
| ZorgaanbiederIdentificatienummer | 11112222 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Trombosedienst Ons Dorp | |||
| AfdelingSpecialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Adresgegevens | Werkadres: Kerkstraat 28 d 1332GH Ons Dorp | |||
1.12 Patiënt J XXX_Eijken
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | J | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Eijken | |||
| Identificatienummer | 999909186 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.12.1 Medicamenteuze behandeling MBH_300_WDS_toekomstWDS
| Medicatieafspraak MBH_300_WDS_toekomstWDS_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_toekomstWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 6 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 6 dagen om 08:00 uur | |||
| Ingangsdatum | T - 6 dagen om 08:00 uur | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Volgens schema trombosedienst, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| AanvullendeInstructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | |||
| MBH identificatie | MBH_300_WDS_toekomstWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| WisselendDoseerschema MBH_300_WDS_toekomstWDS_WDS1 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_toekomstWDS_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| RegistratieDatumTijd | T - 6 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 6 dagen om 08:00 uur, tot en met T + 2 dagen | |||
| Ingangsdatum | T - 6 dagen om 08:00 uur | |||
| Einddatum | T + 2 dagen | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: TANJA_DE_BAKKER | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | eerst gedurende 3 dagen 1 maal per dag 2 stuks, dan gedurende 1 dag 1 maal per dag 3 stuks, dan gedurende 2 dagen 1 maal per dag 2 stuks, dan gedurende 1 dag 1 maal per dag 3 stuks, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie 1 | eerst gedurende 3 dagen 1 maal per dag 2 stuks | |||
| Doseerinstructie 2 | dan gedurende 1 dag 1 maal per dag 3 stuks | |||
| Doseerinstructie 3 | dan gedurende 2 dagen 1 maal per dag 2 stuks | |||
| Doseerinstructie 4 | dan gedurende 1 dag 1 maal per dag 3 stuks | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_WDS_toekomstWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_WDS_toekomstWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| WisselendDoseerschema MBH_300_WDS_toekomstWDS_WDS2 | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_toekomstWDS_WDS2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| RegistratieDatumTijd | T - 3 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T + 2 dagen om 08:00 uur, tot en met T + 16 dagen | |||
| Ingangsdatum | T + 2 dagen om 08:00 uur | |||
| Einddatum | T + 16 dagen | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: TANJA_DE_BAKKER | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | eerst gedurende 6 dagen 1 maal per dag 2 stuks, dan gedurende 1 dag 1 maal per dag 3 stuks, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie 1 | eerst gedurende 6 dagen 1 maal per dag 2 stuks | |||
| Doseerinstructie 2 | dan gedurende 1 dag 1 maal per dag 3 stuks | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_WDS_toekomstWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RelatieWisselendDoseerschema | ||||
| Identificatie | MBH_300_WDS_toekomstWDS_WDS1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| MBH identificatie | MBH_300_WDS_toekomstWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_WDS_toekomstWDS_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_toekomstWDS_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 6 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 6 dagen om 08:00 uur | |||
| Ingangsdatum | T - 6 dagen om 08:00 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Volgens schema trombosedienst, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| AanvullendeInstructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_WDS_toekomstWDS_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_WDS_toekomstWDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener MARCHA_VAN_PARTNERS | ||||
| ZorgverlenerIdentificatienummer | 000001115 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Marcha van Partners | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_ITIS | |||
| Zorgverlener TANJA_DE_BAKKER | ||||
| ZorgverlenerIdentificatienummer | 222221111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Tanja de Bakker | |||
| Specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: TROMBOSEDIENST_ONS_DORP | |||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | ||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Apotheek De Gulle Gaper | |||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_ITIS | ||||
| ZorgaanbiederIdentificatienummer | 00005111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Itis | |||
| Adresgegevens | Werkadres: Langelaan 1 1234ZZ Onze Stad | |||
| Zorgaanbieder TROMBOSEDIENST_ONS_DORP | ||||
| ZorgaanbiederIdentificatienummer | 11112222 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Trombosedienst Ons Dorp | |||
| AfdelingSpecialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Adresgegevens | Werkadres: Kerkstraat 28 d 1332GH Ons Dorp | |||
1.13 Patiënt J XXX_Verstelle
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Initialen | J | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Verstelle | |||
| Identificatienummer | 999909198 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.13.1 Medicamenteuze behandeling MBH_300_WDS_OnderbrokenMA
| Medicatieafspraak MBH_300_WDS_OnderbrokenMA_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_OnderbrokenMA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 4 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 4 dagen om 08:00 uur | |||
| Ingangsdatum | T - 4 dagen om 08:00 uur | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: MARCHA_VAN_PARTNERS | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Volgens schema trombosedienst, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| AanvullendeInstructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | |||
| MBH identificatie | MBH_300_WDS_OnderbrokenMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| WisselendDoseerschema MBH_300_WDS_OnderbrokenMA_WDS | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_OnderbrokenMA_WDS (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.632.1) | |||
| RegistratieDatumTijd | T - 4 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 4 dagen om 08:00 uur, tot en met T + 3 dagen | |||
| Ingangsdatum | T - 4 dagen om 08:00 uur | |||
| Einddatum | T + 3 dagen | |||
| Auteur | ||||
| Zorgverlener | Zie Zorgverlener: TANJA_DE_BAKKER | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | eerst gedurende 4 dagen 1 maal per dag 2 stuks, dan gedurende 1 dag 1 maal per dag 3 stuks, dan gedurende 2 dagen 1 maal per dag 2 stuks, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| Doseerinstructie 1 | eerst gedurende 4 dagen 1 maal per dag 2 stuks | |||
| Doseerinstructie 2 | dan gedurende 1 dag 1 maal per dag 3 stuks | |||
| Doseerinstructie 3 | dan gedurende 2 dagen 1 maal per dag 2 stuks | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_WDS_OnderbrokenMA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_WDS_OnderbrokenMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_WDS_OnderbrokenMA_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_WDS_OnderbrokenMA_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 4 dagen om 08:00 uur | |||
| Gebruiksperiode | Vanaf T - 4 dagen om 08:00 uur | |||
| Ingangsdatum | T - 4 dagen om 08:00 uur | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | ACENOCOUMAROL CF TABLET 1MG (code = '856126' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '7323' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | ACENOCOUMAROL TABLET 1MG (code = '20303' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | Volgens schema trombosedienst, Oraal | |||
| Toedieningsweg | Oraal (code = '9' in codeSystem 'G-Standaard Toedieningswegen (tabel 7)') | |||
| AanvullendeInstructie | overig (code = 'OTH' in codeSystem 'HL7 NullFlavor'): Volgens schema trombosedienst | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_WDS_OnderbrokenMA_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_WDS_OnderbrokenMA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener MARCHA_VAN_PARTNERS | ||||
| ZorgverlenerIdentificatienummer | 000001115 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Marcha van Partners | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_ITIS | |||
| Zorgverlener TANJA_DE_BAKKER | ||||
| ZorgverlenerIdentificatienummer | 222221111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Tanja de Bakker | |||
| Specialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: TROMBOSEDIENST_ONS_DORP | |||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | ||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Apotheek De Gulle Gaper | |||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_ITIS | ||||
| ZorgaanbiederIdentificatienummer | 00005111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Itis | |||
| Adresgegevens | Werkadres: Langelaan 1 1234ZZ Onze Stad | |||
| Zorgaanbieder TROMBOSEDIENST_ONS_DORP | ||||
| ZorgaanbiederIdentificatienummer | 11112222 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Trombosedienst Ons Dorp | |||
| AfdelingSpecialisme | Trombosediensten (code = '3400' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Adresgegevens | Werkadres: Kerkstraat 28 d 1332GH Ons Dorp | |||
1.14 Patiënt A XXX_Maasbommel
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | A | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Achternaam | XXX_Maasbommel | |||
| Identificatienummer | 999908856 [BSN] | |||
| Geboortedatum | 25 feb 1912 | |||
| Geslacht | Man (code = 'M' in codeSystem 'HL7 AdministrativeGender') | |||
1.14.1 Medicamenteuze behandeling MBH_300_spoedtoediening
| Medicatietoediening MBH_300_spoedtoediening_MTD | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_spoedtoediening_MTD (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | |||
| RegistratieDatumTijd | T - 4 dagen om 08:00 uur | |||
| ToedieningsDatumTijd | T - 4 dagen om 08:00 uur | |||
| ToegediendeHoeveelheid | ||||
| Aantal | 2 | |||
| Eenheid | dosis (code = '208' in codeSystem 'G-Standaard thesaurus basiseenheden') | |||
| Toedieningsweg | sublinguaal (code = '121' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Toediener | ||||
| Zorgverlener | Zie Zorgverlener: PETER_VAN_PULVER | |||
| Geneesmiddel - primaire code | NITROLINGUAL OROMUCOSALE SPRAY 0,4MG/DO FLAC 250DO (code = '704369' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | NITROGLYCERINE SPRAY SUBLING. 0,4MG/DO FL 250DO (code = '72214' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | NITROGLYCERINE SPRAY SUBLING. 0,4MG/DO (code = '119431' in codeSystem 'G-Standaard GPK') | |||
| MBH identificatie | MBH_300_spoedtoediening (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener PETER_VAN_PULVER | ||||
| ZorgverlenerIdentificatienummer | 000001111 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Peter van Pulver | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | |||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
1.15 Patiënt A van de XXX_Toorn
| Patiënt | ||||
| Gegevenselement | Waarde | |||
| Naamgegevens | ||||
| Voornamen | A | |||
| Naamgebruik | Eigen geslachtsnaam (code = 'NL1' in codeSystem 'ZIB Naamgebruik') | |||
| Geslachtsnaam | ||||
| Voorvoegsels | van de | |||
| Achternaam | XXX_Toorn | |||
| Identificatienummer | 999908868 [BSN] | |||
| Geboortedatum | 18 sep 1963 | |||
| Geslacht | Vrouw (code = 'F' in codeSystem 'HL7 AdministrativeGender') | |||
1.15.1 Medicamenteuze behandeling MBH_300_prikplak
| Medicatieafspraak MBH_300_prikplak_MA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_prikplak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| RegistratieDatumTijd | T - 51 dagen om 08:05 uur | |||
| Gebruiksperiode | Vanaf T - 50 dagen | |||
| Ingangsdatum | T - 50 dagen | |||
| Voorschrijver | ||||
| Zorgverlener | Zie Zorgverlener: BERTINE_VAN_DOORN | |||
| Geneesmiddel - primaire code | INSULINE ASPART INJVLST 100E/ML PATR 3ML (code = '53902' in codeSystem 'G-Standaard PRK') | |||
| Geneesmiddel - generiekere code | INSULINE ASPART INJVLST 100E/ML (code = '108251' in codeSystem 'G-Standaard GPK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 dosis, subcutaan | |||
| Toedieningsweg | subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 dosis | |||
| MBH identificatie | MBH_300_prikplak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Toedieningsafspraak MBH_300_prikplak_TA | ||||
| Gegevenselement | Waarde | |||
| Identificatie | MBH_300_prikplak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | |||
| RegistratieDatumTijd | T - 51 dagen om 08:05 uur | |||
| Gebruiksperiode | Vanaf T - 50 dagen | |||
| Ingangsdatum | T - 50 dagen | |||
| Verstrekker | ||||
| Zorgaanbieder | Zie Zorgaanbieder: APOTHEEK_DE_GULLE_GAPER | |||
| Geneesmiddel - primaire code | NOVORAPID PENFILL INJVLST 100E/ML PATROON 3ML (code = '1185063' in codeSystem 'G-Standaard HPK') | |||
| Geneesmiddel - generiekere code | INSULINE ASPART INJVLST 100E/ML PATR 3ML (code = '53902' in codeSystem 'G-Standaard PRK') | |||
| Gebruiksinstructie | ||||
| Omschrijving | 1 maal per dag 1 dosis, subcutaan | |||
| Toedieningsweg | subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | |||
| Doseerinstructie | 1 maal per dag 1 dosis | |||
| RelatieMedicatieafspraak | ||||
| Identificatie | MBH_300_prikplak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | |||
| MBH identificatie | MBH_300_prikplak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | |||
| Medicatietoediening MBH_300_prikplak_MTD1 | |||||
| Gegevenselement | Waarde | ||||
| Identificatie | MBH_300_prikplak_MTD1 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||||
| RegistratieDatumTijd | T - 3 dagen om 08:10 uur | ||||
| ToedieningsDatumTijd | T - 3 dagen om 08:10 uur | ||||
| ToegediendeHoeveelheid | |||||
| Aantal | 1 | ||||
| Eenheid | dosis (code = '208' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||||
| Toedieningsweg | subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||||
| PrikPlakLocatie | |||||
| AnatomischeLocatie | |||||
| Locatie | structuur van huid van anterieur oppervlak van bovenarm (code = '45981001' in codeSystem 'SNOMED CT') | ||||
| Lateraliteit | links (code = '7771000' in codeSystem 'SNOMED CT') | ||||
| Toediener | |||||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||||
| Geneesmiddel - primaire code | NOVORAPID PENFILL INJVLST 100E/ML PATROON 3ML (code = '1185063' in codeSystem 'G-Standaard HPK') | ||||
| Geneesmiddel - generiekere code | INSULINE ASPART INJVLST 100E/ML PATR 3ML (code = '53902' in codeSystem 'G-Standaard PRK') | ||||
| RelatieMedicatieafspraak | |||||
| Identificatie | MBH_300_prikplak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||
| RelatieToedieningsafspraak | |||||
| Identificatie | MBH_300_prikplak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||
| MBH identificatie | MBH_300_prikplak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||||
| Medicatietoediening MBH_300_prikplak_MTD2 | |||||
| Gegevenselement | Waarde | ||||
| Identificatie | MBH_300_prikplak_MTD2 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||||
| RegistratieDatumTijd | T - 2 dagen om 08:15 uur | ||||
| ToedieningsDatumTijd | T - 2 dagen om 08:15 uur | ||||
| ToegediendeHoeveelheid | |||||
| Aantal | 1 | ||||
| Eenheid | dosis (code = '208' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||||
| Toedieningsweg | subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||||
| PrikPlakLocatie | |||||
| AnatomischeLocatie | |||||
| Locatie | structuur van huid van anterieur oppervlak van bovenarm (code = '45981001' in codeSystem 'SNOMED CT') | ||||
| Lateraliteit | rechts (code = '24028007' in codeSystem 'SNOMED CT') | ||||
| Toediener | |||||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||||
| Geneesmiddel - primaire code | NOVORAPID PENFILL INJVLST 100E/ML PATROON 3ML (code = '1185063' in codeSystem 'G-Standaard HPK') | ||||
| Geneesmiddel - generiekere code | INSULINE ASPART INJVLST 100E/ML PATR 3ML (code = '53902' in codeSystem 'G-Standaard PRK') | ||||
| RelatieMedicatieafspraak | |||||
| Identificatie | MBH_300_prikplak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||
| RelatieToedieningsafspraak | |||||
| Identificatie | MBH_300_prikplak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||
| MBH identificatie | MBH_300_prikplak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||||
| Medicatietoediening MBH_300_prikplak_MTD3 | |||||
| Gegevenselement | Waarde | ||||
| Identificatie | MBH_300_prikplak_MTD3 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||||
| RegistratieDatumTijd | T - 1 dag om 08:09 uur | ||||
| ToedieningsDatumTijd | T - 1 dag om 08:09 uur | ||||
| ToegediendeHoeveelheid | |||||
| Aantal | 1 | ||||
| Eenheid | dosis (code = '208' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||||
| Toedieningsweg | subcutaan (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||||
| PrikPlakLocatie | |||||
| AnatomischeLocatie | |||||
| Locatie | structuur van weke delen van laterale bovenkwadrant van anterieur oppervlak van bovenbeen (code = '160521000146106' in codeSystem 'SNOMED CT') | ||||
| Lateraliteit | links (code = '7771000' in codeSystem 'SNOMED CT') | ||||
| Toediener | |||||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||||
| Geneesmiddel - primaire code | NOVORAPID PENFILL INJVLST 100E/ML PATROON 3ML (code = '1185063' in codeSystem 'G-Standaard HPK') | ||||
| Geneesmiddel - generiekere code | INSULINE ASPART INJVLST 100E/ML PATR 3ML (code = '53902' in codeSystem 'G-Standaard PRK') | ||||
| RelatieMedicatieafspraak | |||||
| Identificatie | MBH_300_prikplak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||
| RelatieToedieningsafspraak | |||||
| Identificatie | MBH_300_prikplak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||
| MBH identificatie | MBH_300_prikplak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||||
| Medicatietoediening MBH_300_prikplak_MTD4 | |||||
| Gegevenselement | Waarde | ||||
| Identificatie | MBH_300_prikplak_MTD4 (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.18629005.1) | ||||
| RegistratieDatumTijd | T om 08:04 uur | ||||
| ToedieningsDatumTijd | T om 08:04 uur | ||||
| ToegediendeHoeveelheid | |||||
| Aantal | 1 | ||||
| Eenheid | dosis (code = '208' in codeSystem 'G-Standaard thesaurus basiseenheden') | ||||
| Toedieningsweg | stuk (code = '21' in codeSystem 'G-Standaard Toedieningswegen') | ||||
| PrikPlakLocatie | |||||
| AnatomischeLocatie | |||||
| Locatie | structuur van weke delen van laterale bovenkwadrant van anterieur oppervlak van bovenbeen (code = '160521000146106' in codeSystem 'SNOMED CT') | ||||
| Lateraliteit | rechts (code = '24028007' in codeSystem 'SNOMED CT') | ||||
| Toediener | |||||
| Zorgverlener | Zie Zorgverlener: JANTIEN_TOEDIEN | ||||
| Geneesmiddel - primaire code | NOVORAPID PENFILL INJVLST 100E/ML PATROON 3ML (code = '1185063' in codeSystem 'G-Standaard HPK') | ||||
| Geneesmiddel - generiekere code | INSULINE ASPART INJVLST 100E/ML PATR 3ML (code = '53902' in codeSystem 'G-Standaard PRK') | ||||
| RelatieMedicatieafspraak | |||||
| Identificatie | MBH_300_prikplak_MA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.16076005.1) | ||||
| RelatieToedieningsafspraak | |||||
| Identificatie | MBH_300_prikplak_TA (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.422037009.1) | ||||
| MBH identificatie | MBH_300_prikplak (in identificerend systeem: 2.16.840.1.113883.2.4.3.11.999.77.1.1) | ||||
| Bouwstenen | ||||
| Gegevenselement | Waarde | |||
| Zorgverlener BERTINE_VAN_DOORN | ||||
| ZorgverlenerIdentificatienummer | 000001112 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Bertine van Doorn | |||
| Specialisme | Huisartsen, niet nader gespecificeerd (code = '0100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | |||
| Zorgverlener JANTIEN_TOEDIEN | ||||
| ZorgverlenerIdentificatienummer | 222220000 (in identificerend systeem: UZI Personen) | |||
| Naamgegevens | Jantien Toedien | |||
| Specialisme | Verpleegkundigen, niet nader gespecificeerd (code = '9100' in codeSystem 'COD016-VEKT Vektis Zorgverlenersspecificatie (subberoepsgroep)') | |||
| Zorgaanbieder | ||||
| Zorgaanbieder | Zie Zorgaanbieder: THUISZORG_OM_EN_BIJ | |||
| Zorgaanbieder APOTHEEK_DE_GULLE_GAPER | ||||
| ZorgaanbiederIdentificatienummer | 01236578 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Apotheek De Gulle Gaper | |||
| Adresgegevens | Werkadres: Dorpsstraat 12 A 1234AA Ons Dorp | |||
| Zorgaanbieder HUISARTSENPRAKTIJK_PULVER_EN_PARTNERS | ||||
| ZorgaanbiederIdentificatienummer | 00001111 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Huisartsenpraktijk Pulver & Partners | |||
| Adresgegevens | Werkadres: Dorpsstraat 1 1234AA Ons Dorp | |||
| Zorgaanbieder THUISZORG_OM_EN_BIJ | ||||
| ZorgaanbiederIdentificatienummer | 11110000 (in identificerend systeem: URA) | |||
| OrganisatieNaam | Thuiszorg Om en Bij | |||
| OrganisatieType | Thuiszorg (code = 'T2' in codeSystem 'HL7 RoleCodeNL Care provider type (organizations)') | |||